{"text": "Overall a reduction of the tumour volume of more than 20 % was observed in 39 % of the patients during treatment with Octreotide followed by Pasireotide .", "label": "", "metadata": {}, "score": "30.096603"}
{"text": "This is a multi - center , open label , phase IV study to provide continued supply of pasireotide to patients being treated in a current Novartis - sponsored , Oncology CD&MA study and who are benefiting from treatment with pasireotide .", "label": "", "metadata": {}, "score": "33.262203"}
{"text": "4142 - 4146 , 2002 .View at Publisher \u00b7 View at Google Scholar .C. B. Newman , S. Melmed , A. George et al . , \" Octreotide as primary therapy for acromegaly , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "36.351128"}
{"text": "5 , pp .873 - 881 , 1989 .View at Google Scholar \u00b7 View at Scopus .M. L. Vance and A. G. Harris , \" Long - term treatment of 189 acromegalic patients with the somatostatin analog octreotide : results of the International Multicenter Acromegaly Study Group , \" Archives of Internal Medicine , vol .", "label": "", "metadata": {}, "score": "37.380867"}
{"text": "In this series , treatment with octreotide LAR led to a worsening of glucose tolerance in three non - diabetic patients and worsened glycemic control in two diabetics , in spite of reducing insulin resistance .", "label": "", "metadata": {}, "score": "37.676205"}
{"text": "Both inhibit the progression of the cell cycle and induce apoptosis .A recently published study , compared Octreotide and Pasireotide ( Octreotide 100 \u03bc g s.c .", "label": "", "metadata": {}, "score": "37.7479"}
{"text": "Keywords : Acromegaly ; Somatostatin receptor ; Dopamine receptor ; Octreotide LAR \u00ae .The purpose of this study is to allow continued use of pasireotide in patients who are on pasireotide treatment in a Novartis - sponsored , Oncology Clinical Development & Medical Affairs ( CD&MA ) study and are benefiting from the treatment as judged by the investigator .", "label": "", "metadata": {}, "score": "37.836388"}
{"text": "4 , pp .446 - 450 , 1993 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. J. Quabbe and U. Plockinger , \" Dose - response study and long term effect of the somatostatin analog octreotide in patients with therapy - resistant acromegaly , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "37.88269"}
{"text": "4 , pp .395 - 405 , 1987 .View at Google Scholar . D. Sautner , W. Saeger , G. Tallen , D. K. Ludecke , and W. Rehpenning , \" Effects of octreotide on morphology of pituitary adenomas in acromegaly , \" Pathology Research and Practice , vol .", "label": "", "metadata": {}, "score": "37.928738"}
{"text": "It is noteworthy that patients who have a good biochemical response or disease stabilization with octreotide treatment stain positive for SSTR2 .Those patients who are non - respon- sive are negative for SSTR2 staining [ 21].", "label": "", "metadata": {}, "score": "37.995037"}
{"text": "Preview \u00b7 Article \u00b7 Nov 2005 \u00b7 Arquivos Brasileiros de Endocrinologia & Metabologia Efficacy and Safety of High Dose Regimen of Octreotide LAR in Patients With Neuroendocrine Tumors in Progressive Disease : A Phase II , Open , Multicentric Prospective Study .", "label": "", "metadata": {}, "score": "38.552948"}
{"text": "Patient is currently benefiting from the treatment with pasireotide , as determined by the investigator .Patient has demonstrated compliance , as assessed by the investigator , with the parent study requirements .", "label": "", "metadata": {}, "score": "39.27731"}
{"text": "In many case reports published during the past decade , somatostatin analogues were routinely discontinued once pregnancy was diag- nosed .Page 2 . two women octreotide LAR was administered [ 12,15].", "label": "", "metadata": {}, "score": "39.740948"}
{"text": "Conclusion : This case adds more data supporting the potential for the safe use of octreotide and the feasibility of octreotide LAR use during pregnancy , making compliance with the patient 's preference not to withdraw octreotide therapy as soon as her pregnancy is confirmed a thoughtful option .", "label": "", "metadata": {}, "score": "39.76843"}
{"text": "6 , pp .1658 - 1662 , 1990 .View at Google Scholar \u00b7 View at Scopus . U.Pl\u00f6ckinger , A. Perez - Canto , C. Emde , R.-M. Liehr , W. Hopfenm\u00fcller , and H.-J. Quabbe , \" Effect of the somatostatin analog octreotide on gastric mucosal function and histology during 3 months of preoperative treatment in patients with acromegaly , \" European Journal of Endocrinology , vol .", "label": "", "metadata": {}, "score": "39.877502"}
{"text": "Official Title : .A Randomized , Double - blind , Multicenter , Phase III Study to Evaluate the Efficacy and Safety of Pasireotide LAR in Patients With Cushing 's Disease .", "label": "", "metadata": {}, "score": "40.077522"}
{"text": "638 - 645 , 2004 .View at Publisher \u00b7 View at Google Scholar .S. Petersenn , J. Schopohl , A. Barkan et al . , \" Pasireotide ( SOM230 ) demonstrates efficacy and safety in patients with acromegaly : a randomized , multicenter , phase II trial , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "40.29805"}
{"text": "6 , pp .899 - 906 , 2006 .View at Publisher \u00b7 View at Google Scholar .R. A. Kristof , B. Stoffel - Wagner , D. Klingm\u00fcller , and J. Schramm , \" Does octreotide treatment improve the surgical results of macro - adenomas in acromegaly ?", "label": "", "metadata": {}, "score": "40.451385"}
{"text": "All patients at their scheduled visits will have drug dispensing information and reported adverse events and serious adverse events collected .A patient will reach the end of study when pasireotide treatment is permanently discontinued and the end of treatment visit has been performed .", "label": "", "metadata": {}, "score": "40.676735"}
{"text": "The study is expected to remain open for approximately 10 years or until such time that enrolled patients no longer need treatment with pasireotide or are able to obtain commercial supply according to local regulations for their medical condition .", "label": "", "metadata": {}, "score": "40.873337"}
{"text": "The study is expected to remain open for approximately 10 years or until such time that enrolled patients no longer need treatment with pasireotide or are able to obtain commercial supply according to local regulations for their medical condition .", "label": "", "metadata": {}, "score": "40.873337"}
{"text": "Herein we present the first case report describing a patient who delivered three healthy babies following three consecutive pregnan- cies while being treated with octreotide LAR for residual ectopic EAS .", "label": "", "metadata": {}, "score": "41.666443"}
{"text": "10 , pp .3308 - 3314 , 1997 .View at Publisher \u00b7 View at Google Scholar . A. Stevenaert and A. Beckers , \" Presurgical octreotide : treatment in acromegaly , \" Metabolism : Clinical and Experimental , vol .", "label": "", "metadata": {}, "score": "41.735252"}
{"text": "Octreotide LAR treatment was continued throughout this time period .Recent routine follow - up chest tomography 10 years after the patient 's initial presentation revealed normal mediastinal lymph nodes , with permanent post - surgical changes at the basal portion of the left lung .", "label": "", "metadata": {}, "score": "42.143517"}
{"text": "Subcutaneous SRL Treatment .Octreotide and Lanreotide are cyclic peptides with a significantly prolonged half - life compared to somatostatin ( 2 hours versus 2 minutes ) .", "label": "", "metadata": {}, "score": "42.243073"}
{"text": "Additional case reports are needed to verify the safety of octreotide and octreotide LAR therapy during pregnancy .Conclusions First , our report demonstrates increased evidence for the safety of octreotide treatment throughout pregnancy in addition to that described in the seven previous case reports of safe octreotide therapy , using short- or long- acting preparations , during pregnancy .", "label": "", "metadata": {}, "score": "42.386208"}
{"text": "No significant difference of therapeutic efficacy was reported [ 119 , 134 , 135 ] .A publication from Baldelli et al . reported an even better result for primary therapy using Lanreotide SR [ 136 ] .", "label": "", "metadata": {}, "score": "42.551224"}
{"text": "Again there was no difference between Octreotide LAR and Lanreotide Autogel [ 83 ] .The comparable efficacy of both , Octreotide LAR and Lanreotide Autogel has been further confirmed in a meta - analysis investigating the potency of different SRL formulations [ 84 ] .", "label": "", "metadata": {}, "score": "42.73593"}
{"text": "141 , no .4 , pp .399 - 405 , 1999 .View at Publisher \u00b7 View at Google Scholar .S. M. Carlsen , M. Lund - Johansen , T. Schreiner et al . , \" Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short - term postoperative rates : a prospective , randomized trial , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "42.86006"}
{"text": "The efficacy of the depot preparation should not be evaluated before steady - state drug concentrations have been achieved , that is , after 3 injections for Octreotide LAR .", "label": "", "metadata": {}, "score": "42.979904"}
{"text": "While Lanreotide SR has been shown to be slightly less effective than Octreotide LAR , a comparable efficacy has been demonstrated for Octreotide LAR and Lanreotide Autogel in two clinical trials [ 81 , 82 ] .", "label": "", "metadata": {}, "score": "43.181957"}
{"text": "4 , pp .477 - 483 , 2001 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. R. Grunstein , K. K. Y. Ho , and C. E. Sullivan , \" Effect of octreotide , a somatostatin analog , on sleep apnea in patients with acromegaly , \" Annals of Internal Medicine , vol .", "label": "", "metadata": {}, "score": "43.25991"}
{"text": "OBJECTIVE :This prospective randomized study evaluated the efficacy and safety of octreotide LAR vs. surgery in newly diagnosed acromegalic patients .METHODS : Totally 104 male and female patients were enrolled in a 50-week , exploratory , open - label and randomized study .", "label": "", "metadata": {}, "score": "43.35444"}
{"text": "Octreotide LAR , Lanreotide SR and Lanreotide autogel : 14 weeks .Patients who are considered candidates for surgical treatment at the time of study entry .", "label": "", "metadata": {}, "score": "43.394615"}
{"text": "The slow release formulations Octreotide LAR and Lanreotide Autogel are equally effective .Up to 60 % of the patients will achieve complete remission and the rate increases with prolonged treatment .", "label": "", "metadata": {}, "score": "43.62164"}
{"text": "105 - 114 , 1999 .View at Google Scholar \u00b7 View at Scopus .J. Schopohl , C. J. Strasburger , D. Caird et al . , \" Efficacy and acceptability of lanreotide autogel 120 mg at different dose intervals in patients with acromegaly previously treated with octreotide LAR , \" Experimental and Clinical Endocrinology and Diabetes , vol .", "label": "", "metadata": {}, "score": "43.780247"}
{"text": "4 , pp .430 - 439 , 1995 .View at Google Scholar .U.Plockinger , D. Dienemann , and H. J. Quabbe , \" Gastrointestinal side - effects of octreotide during long term treatment of acromegaly , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "43.85768"}
{"text": "Chronic octreotide LAR injections were initiated as indicated by a positive octreoscan .Follow - up revealed a long - lasting positive response to octreotide .", "label": "", "metadata": {}, "score": "43.89057"}
{"text": "OBJECTIVE :To delineate the role of pegvisomant in the treatment ... .The use of octreotide - LAR and cabergoline therapy has shown great promise in adults with acromegaly ; however , the experience in pediatric patients has rarely been reported .", "label": "", "metadata": {}, "score": "44.209618"}
{"text": "Using the chicken chorioallantoic membrane model Barrie et al .demonstrated the most pronounced antiangiogenetic effect by those SRL which preferentially activate sst2 , like Octreotide or RC-160 [ 74 ] .", "label": "", "metadata": {}, "score": "44.36474"}
{"text": "5 , pp .559 - 564 , 1995 .View at Google Scholar \u00b7 View at Scopus .G. Minniti , M. L. Jaffrain - Rea , R. Baldelli et al . , \" Acute effects of octreotide , cabergoline and a combination of both drugs on GH secretion in acromegalic patients , \" Clinica Terapeutica , vol .", "label": "", "metadata": {}, "score": "44.429863"}
{"text": "Thus Pasireotide may be especially effective in these patients .The high affinity of Pasireotide for sst1 and sst3 may prove to be an advantage for the stabilisation of tumour growth .", "label": "", "metadata": {}, "score": "44.60843"}
{"text": "However , the negative effect on glucose metabolism was more pronounced with Pasireotide [ 141 ] .Somatoprim A recently developed somatostatin multi - receptor ligand , Somatoprim , may be at least as potent , as Octreotide , but without a negative effect on glucose metabolism .", "label": "", "metadata": {}, "score": "44.64749"}
{"text": "Patients who have had any previous pasireotide treatment .Patients who have been treated with mitotane during the last 6 months prior to Visit 1 .", "label": "", "metadata": {}, "score": "44.69382"}
{"text": "11 , pp .5194 - 5200 , 2001 .View at Publisher \u00b7 View at Google Scholar .K. Thapar , K. T. Kovacs , L. Stefaneanu et al . , \" Antiproliferative effect of the somatostatin analogue octreotide on growth hormone - producing pituitary tumors : results of a multicenter randomized trial , \" Mayo Clinic Proceedings , vol .", "label": "", "metadata": {}, "score": "45.082302"}
{"text": "4 , pp .519 - 528 , 1992 .View at Google Scholar \u00b7 View at Scopus .S. Ezzat , E. Horvath , A. G. Harris , and K. Kovacs , \" Morphological effects of octreotide on growth hormone - producing pituitary adenomas , \" Journal of Clinical Endocrinology and Metabolism , vol . 79 , no . 1 , pp .", "label": "", "metadata": {}, "score": "45.434696"}
{"text": "By developing long - acting slow - release SSA formulation , long - acting OCT ( LAR ) , lanreotide - SR , lanreotide - Autogel , the patient 's compliance to SSA therapy was improved and escape from treatment , which was common with the subcutaneous formulation , was avoided .", "label": "", "metadata": {}, "score": "45.466473"}
{"text": "In comparison to Octreotide , Pasireotide has a longer half - life ( 2 hours versus 27 hours ) [ 140 ] .This may be related to the intracellular dynamic of the sst2- and sst5-receptor - ligand complex .", "label": "", "metadata": {}, "score": "45.685635"}
{"text": "Using 1 microg / L as a cut off level for \" safe \" GH , the prevalence of discordance was 3.9 % , 8.6 % and 28.6 % at diagnosis , after surgery and during treatment with octreotide LAR , respectively .", "label": "", "metadata": {}, "score": "46.09497"}
{"text": "After undergoing surgical removal of a mass by left lower lung lobectomy , her residual lung disease medical therapy failed .Chronic octreotide LAR injections were initiated as indicated by a positive octreoscan .", "label": "", "metadata": {}, "score": "46.132015"}
{"text": "Neal JM : Successful pregnancy in a woman with acromegaly treated with octreotide .Endocr Pract 2000 , 6:148 - 150 .Fassnacht M , Capeller B , Arlt W , Steck T , Allolio B : Octreotide LAR treatment throughout pregnancy in an acromegalic woman .", "label": "", "metadata": {}, "score": "46.308655"}
{"text": "Multiple Endocrine Neoplasia .Intervention ICMJE .Drug : Octreotide - LAR .Octreotide - LAR 30 mg administered every 21 days until progression .Other Names : .", "label": "", "metadata": {}, "score": "46.326046"}
{"text": "Fetal exposure to octreotide due to placental transfer and increased half - life in fetal serum has raised concern about its potential hazard to the fetus [ 9].", "label": "", "metadata": {}, "score": "46.41851"}
{"text": "137 - 145 , 2001 .View at Google Scholar .N. R. Biermasz , H. Van Dulken , and F. Roelfsema , \" Direct postoperative and follow - up results of transsphenoidal surgery in 19 acromegalic patients pretreated with octreotide compared to those in untreated matched controls , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "46.467743"}
{"text": "10 - 14 , 1994 .View at Google Scholar \u00b7 View at Scopus . A. Colao , D. Ferone , P. Cappabianca et al . , \" Effect of octreotide pretreatment on surgical outcome in acromegaly , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "46.49161"}
{"text": "Slow release formulations are more convenient for the patients and thus compliance is increased .Difficulties with injecting Octreotide LAR or Lanreotide Autogel can be reduced by delivering the injections with the help of specifically trained personnel .", "label": "", "metadata": {}, "score": "46.559586"}
{"text": "AIM : To determine whether folic acid supplementation will reduce the recurrence of colorectal adenomas , the precursors of colorectal cancer , we performed a double - blind placebo - controlled trial in patients with adenomatous polyps .", "label": "", "metadata": {}, "score": "46.63898"}
{"text": "16 , pp .1171 - 1177 , 2000 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . E. Ghigo , B. M. K. Biller , A. Colao et al . , \" Comparison of pegvisomant and long - acting octreotide in patients with acromegaly na\u00efve to radiation and medical therapy , \" Journal of Endocrinological Investigation , vol .", "label": "", "metadata": {}, "score": "46.644646"}
{"text": "However , sst5 is rapidly and extensively recycled from intracellular stores back into the cell membrane .Due to its long half - life , Pasireotide can bind again to the recycled sst5 .", "label": "", "metadata": {}, "score": "46.96007"}
{"text": "In another report , investigators found scanty binding of somatostatin and its analogues to both placental and umbilical cord diverse SSTR1 through SSTR5 [ 13 ] , which caused the maternal - fetal barrier to sufficiently hamper the func- tional response of SSTR1 through SSTR5 response to octreotide .", "label": "", "metadata": {}, "score": "47.13309"}
{"text": "156 - 162 , 2011 .View at Publisher \u00b7 View at Google Scholar .S. W. van Thiel , J. A. Romijn , N. R. Biermasz et al . , \" Octreotide long - acting repeatable and lanreotide Autogel are equally effective in controlling growth hormone secretion in acromegalic patients , \" European Journal of Endocrinology , vol .", "label": "", "metadata": {}, "score": "47.176373"}
{"text": "Boulanger C , Vezzosi D , Bennet A , Lorenzini F , Fauvel J , Caron P : Normal pregnancy in a woman with nesidioblastosis treated with somatostatin analog octreotide .", "label": "", "metadata": {}, "score": "47.328613"}
{"text": "studied the acute effect of the combination of Octreotide s.c . and Cabergoline in 21 patients with acromegaly .In 14 patients with insufficient response to either drug , combination therapy was initiated ( Octreotide 100 \u03bc g s.c . plus Cabergoline 0.5 mg p.o .", "label": "", "metadata": {}, "score": "47.685356"}
{"text": "J Clin Endocrinol Metab 1996 , 81:1164 - 1168 .Chanson P , Timsit J , Harris AG : Clinical pharmacokinetics of octreotide : therapeutic applications in patients with pituitary tumours .", "label": "", "metadata": {}, "score": "47.712868"}
{"text": "Seven cases in the literature have reported the safe and effective use of octreotide for the treatment of nesi- dioblastosis , acromegaly , and TSH - secreting pituitary macroadenoma throughout pregnancy .", "label": "", "metadata": {}, "score": "47.81519"}
{"text": "The present study was designed to investigate the localization of VEGF in GH - secreting pituitary adenomas and to evaluate the characteristic differences of VEGF expression in relation to the clinical effect of preoperative treatment with octreotide .", "label": "", "metadata": {}, "score": "48.01573"}
{"text": "4 , pp .569 - 574 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. S. Jallad and M. D. Bronstein , \" Optimizing medical therapy of acromegaly : beneficial effects of cabergoline in patients uncontrolled with long - acting release octreotide , \" Neuroendocrinology , vol .", "label": "", "metadata": {}, "score": "48.03075"}
{"text": "The present report is a large series examining SSTR mRNA levels in somatotropinomas and NFPA .These initial findings suggest that detailed knowledge of the SSTR mRNA expression profile in somatotropinomas can help to predict the hormonal response to therapy with LAR .", "label": "", "metadata": {}, "score": "48.056686"}
{"text": "Octreoscan scintigraphy helps select carcinoid patients for somatostatin analogue treatment [ 19].A positive octreoscan indicates binding of the analogue for investi- gation ( 111In - diethylenetriaminepentaacetic acid - D - Phe1 ] octreotide ) to SSTR sub - types 2 , 3 , and 5 [ 20].", "label": "", "metadata": {}, "score": "48.09987"}
{"text": "de Menis E , Billeci D , Marton E : Uneventful pregnancy in an acromegalic patient treated with slow - release lanreotide : a case report .", "label": "", "metadata": {}, "score": "48.212303"}
{"text": "2907 - 2914 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Arosio , S. Macchelli , C. M. Rossi , G. Casati , O. Biella , and G. Faglia , \" Effects of treatment with octreotide in acromegalic patients - a multicenter Italian study , \" European Journal of Endocrinology , vol .", "label": "", "metadata": {}, "score": "48.4215"}
{"text": "last dose and 3 months after pasireotide LAR last dose and should not father a child in this period .Choosing to participate in a study is an important personal decision .", "label": "", "metadata": {}, "score": "48.434315"}
{"text": "Full - text .This report provides the first documentation of uneventful octreotide LAR use during three pregnancies in a woman with bronchial carcinoid - associated adrenocorticotropic hormone - dependent Cushing 's syndrome .", "label": "", "metadata": {}, "score": "48.529774"}
{"text": "10 , pp .4123 - 4130 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. Van Der Hoek , W. W. De Herder , R. A. Feelders et al . , \" A single - dose comparison of the acute effects between the new Somatostatin analog SOM230 and octreotide in acromegalic patients , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "48.63303"}
{"text": "To assess the efficacy of two Pasireotide LAR ( long acting release ) regimens independently in patients with Cushing 's disease after 7 months of treatment regardless of up titration at month 4 .", "label": "", "metadata": {}, "score": "48.709084"}
{"text": "If these in vitro data are confirmed in vivo in acromegalic patients , Somatoprim will be a valuable alternative to other SRL .Chimeric Molecules Another approach has been the development of \" chimeric \" molecules .", "label": "", "metadata": {}, "score": "48.87657"}
{"text": "These data demonstrate the possibility of active acromegaly even with very low GH concentrations .Thus stricter criteria , using a sensitive monoclonal assay , have been proposed .", "label": "", "metadata": {}, "score": "49.503723"}
{"text": "1416 - 1423 , 1994 .View at Publisher \u00b7 View at Google Scholar .S. Barakat and S. Melmed , \" Reversible shrinkage of a growth hormone - secreting pituitary adenoma by a long - acting somatostatin analogue , octreotide , \" Archives of Internal Medicine , vol .", "label": "", "metadata": {}, "score": "49.51793"}
{"text": "Hence , presence of sst5TMD4 associates with increased aggressive features and worse prognosis in somatotropinomas , thereby providing a potentially useful tool to refine somatotropinoma diagnosis , predict outcome of clinical response to SSA - therapy and develop new therapeutic targets .", "label": "", "metadata": {}, "score": "49.79597"}
{"text": "In 1972 Liuzzi et al . detected the paradox GH - reducing effect of L - Dopa in patients with acromegaly [ 147 ] .This resulted in the development of the \" first - generation \" dopamine agonist preparation , Bromocriptine , and was soon followed by \" second - generation \" dopamine agonists such as Cabergoline and Quinagolide ( a nonergot dopamine agonist ) .", "label": "", "metadata": {}, "score": "50.175262"}
{"text": "For a detailed discussion of antiangiogenetic effects of SRL see Dasgupta [ 69 ] .Somatostatin Receptor Ligands Octreotide and Lanreotide The clinical available somatostatin analogues Octreotide and Lanreotide demonstrate a high affinity for sst2 and a moderate affinity for sst5 .", "label": "", "metadata": {}, "score": "50.17771"}
{"text": "Conventional PCR and sequencing were used to identify gsp+ tumors .Quantitative real - time PCR was used to determine SSTR and DR tumor expression .", "label": "", "metadata": {}, "score": "50.19467"}
{"text": "doi:10.1186/1752 - 1947 - 5 - 386 Cite this article as : Naccache et al .: Uneventful octreotide LAR therapy throughout three pregnancies , with favorable delivery and anthropometric measures for each newborn : a case report .", "label": "", "metadata": {}, "score": "50.30464"}
{"text": "compared the efficacy of Pegvisomant and Octreotide LAR in an open randomized multicentre study in 152 acromegalic patients .The normalisation rate of IGF-1 was similar in both groups , but Pegvisomant was more effective in those patients with higher IGF-1 baseline levels [ 179 ] .", "label": "", "metadata": {}, "score": "50.31142"}
{"text": "Endpoint Classification : Safety Study Intervention Model : Single Group Assignment Masking : Open Label Primary Purpose : Treatment .Official Title : .An Open Label , Multi - center Pasireotide Roll - over Protocol for Patients Who Have Completed a Previous Novartis - sponsored Pasireotide Study and Are Judged by the Investigator to Benefit From Continued Pasireotide Treatment .", "label": "", "metadata": {}, "score": "50.39212"}
{"text": "As has been already mentioned , no tumour lacking sst2A immuno - histochemical positivity demonstrated an effect of SRL therapy [ 66 ] .Somatostatin scintigraphy does not correlate with the effects of SRL on GH [ 103 ] .", "label": "", "metadata": {}, "score": "50.641624"}
{"text": "Exclusion Criteria : .Patient has been permanently discontinued from pasireotide study treatment in the parent study due to unacceptable toxicity , non - compliance to study procedures , withdrawal of consent or any other reason .", "label": "", "metadata": {}, "score": "51.314285"}
{"text": "3090 - 3098 , 2003 .View at Publisher \u00b7 View at Google Scholar . A. Colao , D. Ferone , P. Marzullo et al . , \" Long - term effects of depot long - acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "51.426666"}
{"text": "found a significantly better surgical outcome for those patients pretreated with SRL ( 50 % versus 16 % ) [ 129 ] .Thus it is still an open question whether presurgical therapy with subsequent tumour shrinkage really improves short- or long - term outcome of transsphenoidal surgery in acromegaly .", "label": "", "metadata": {}, "score": "51.808784"}
{"text": "Though not essential for therapeutic deci- sion making , SSTR sub - typing may elucidate our under- standing of this rare and heterogeneous disease .Octreotide crosses the placenta , where it remains stable [ 12,13,15,22,23].", "label": "", "metadata": {}, "score": "51.86664"}
{"text": "To evaluate the safety and effectiveness of lanreotide Autogel on growth hormone and insulinlike growth factor 1 ( IGF-1 ) concentrations and tumor size in patients with acromegaly .", "label": "", "metadata": {}, "score": "51.86817"}
{"text": "Arq Bras Endocrinol Metab [ online].2008 , vol.52 , n.8 , pp .1288 - 1295 .ISSN 1677 - 9487 .We present two acromegalic patients in which clinical and molecular data are discussed in regard to their ability to predict long term octreotide LAR \u00ae therapy response .", "label": "", "metadata": {}, "score": "51.961483"}
{"text": "The seven patients unresponsive to Quinagolide were subjected to a combination therapy of Octreotide ( 600 \u03bc g / d ) , and Quinagolide ( 600 \u03bc g / d ) for three months .", "label": "", "metadata": {}, "score": "52.005497"}
{"text": "82 - 92 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. Mattar , M. R. Alves Martins , and J. Abucham , \" Short - and long - term efficacy of combined cabergoline and octreotide treatment in controlling IGF - I levels in acromegaly , \" Neuroendocrinology , vol .", "label": "", "metadata": {}, "score": "52.068848"}
{"text": "With the depot preparation the injection is easily performed , if instructions for preparing the intramuscular injection are properly adhered to .Lanreotide Autogel can be self - injected by the patients .", "label": "", "metadata": {}, "score": "52.141975"}
{"text": "View at Google Scholar . A. Lupp , A. Hunder , A. Petrich , F. Nagel , C. Doll , and S. Schulz , \" Reassessment of sst 5 somatostatin receptor expression in normal and neoplastic human tissues using the novel rabbit monoclonal antibody UMB-4 , \" Neuroendocrinology , vol .", "label": "", "metadata": {}, "score": "52.294144"}
{"text": "721 - 727 , 2004 .View at Google Scholar .P. Jaquet , G. Gunz , A. Saveanu et al . , \" BIM-23A760 , a chimeric molecule directed towards somatostatin and dopamine receptors , vs universal somatostatin receptors ligands in GH - secreting pituitary adenomas partial responders to octreotide , \" Journal of Endocrinological Investigation , vol .", "label": "", "metadata": {}, "score": "52.373043"}
{"text": "In monkeys Octreotide inhibits the GH secretion 45 times more than somatostatin [ 75 ] .Initially Octreotide was available for thrice daily subcutaneous injections .", "label": "", "metadata": {}, "score": "52.495632"}
{"text": "931 - 933 , 2010 .View at Publisher \u00b7 View at Google Scholar The safety of octreotide use , in its short - acting preparation , in pregnancy is still unclear .", "label": "", "metadata": {}, "score": "52.519554"}
{"text": "Octreotide ( OCT ) is a somatostatin analogue ( SSA ) available in a long - acting formulation , conventionally administered every 28 days at the maximum dose of 30 mg .", "label": "", "metadata": {}, "score": "52.684418"}
{"text": "3034 - 3040 , 1998 .View at Publisher \u00b7 View at Google Scholar .R. Baldelli , A. Colao , P. Razzore et al . , \" Two - year follow - up of acromegalic patients treated with slow release lanreotide ( 30 mg ) , \" Journal of Clinical Endocrinology and Metabolism , vol . 85 , no .", "label": "", "metadata": {}, "score": "53.097588"}
{"text": "Against our instructions , the patient had three spontaneous pregnancies leading to delivery of three full - term healthy children while her octreotide LAR therapy continued .", "label": "", "metadata": {}, "score": "53.232037"}
{"text": "115 - 120 , 1999 .View at Google Scholar \u00b7 View at Scopus .R. Cozzi , R. Attanasio , S. Lodrini , and G. Lasio , \" Cabergoline addition to depot somatostatin analogues in resistant acromegalic patients : efficacy and lack of predictive value of prolactin status , \" Clinical Endocrinology , vol .", "label": "", "metadata": {}, "score": "53.323837"}
{"text": "147 , no .5 , pp .485 - 493 , 2005 .View at Publisher \u00b7 View at Google Scholar .M. Losa , P. Mortini , L. Urbaz , P. Ribotto , T. Castrignan\u00f2 , and M. Giovanelli , \" Presurgical treatment with somatostatin analogs in patients with acromegaly : effects on the remission and complication rates , \" Journal of Neurosurgery , vol .", "label": "", "metadata": {}, "score": "53.32847"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : To evaluate the glucose metabolism in acromegalic patients before and after treatment with octreotide LAR .", "label": "", "metadata": {}, "score": "53.39122"}
{"text": "Janson ET , Gobi A , K\u00e4lkner KM , \u00d6berg K : A comparison between the efficacy of somatostatin receptor scintigraphy and that of in situ hybridization for somatostatin receptor subtype 2 messenger RNA to predict therapeutic outcome in carcinoid patients .", "label": "", "metadata": {}, "score": "53.47631"}
{"text": "10 , pp .3551 - 3555 , 1999 .View at Google Scholar . U.Pl\u00f6ckinger and H.-J. Quabbe , \" Presurgical octreotide treatment in acromegaly : no improvement of final growth hormone ( GH ) concentration and pituitary function .", "label": "", "metadata": {}, "score": "53.491814"}
{"text": "J Clin Pathol 2006 , 59:274 - 279 .Janson ET , Westlin JE , Eriksson B , Ahlstr\u00f6m H , Nilsson S , \u00d6berg K : [ 111In- DTPA - D - Phe1]Octreotide scintigraphy in patients with carcinoid tumors : the predictive value for somatostatin analogue treatment .", "label": "", "metadata": {}, "score": "53.55727"}
{"text": "Maffei P , Tamagno G , Battista Nadrdelli G , Videau C , Menegazzo C , Milan G , Calcagno A , Martini C , Vettor R , Epelbaum J , Sicolo N : Effect of octreotide exposure during pregnancy in acromegaly .", "label": "", "metadata": {}, "score": "53.56376"}
{"text": "2957 - 2968 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. Hradec , J. Kral , T. Janota et al . , \" Regression of acromegalic left ventricular hypertrophy after lanreotide ( a slow - release somatostatin analog ) , \" American Journal of Cardiology , vol .", "label": "", "metadata": {}, "score": "53.789036"}
{"text": "4 , pp .387 - 394 , 1998 .View at Publisher \u00b7 View at Google Scholar .J. A. Gilbert , J. P. Miell , S. M. Chambers , A. M. McGregor , and S. J. B. Aylwin , \" The nadir growth hormone after an octreotide test dose predicts the long - term efficacy of somatostatin analogue therapy in acromegaly , \" Clinical Endocrinology , vol .", "label": "", "metadata": {}, "score": "53.879898"}
{"text": "New developments aim to find SRL with improved ligand - binding characteristics , as Pasireotide ( Pasireotide ) , a multireceptor ligand or chimeric ligands binding to both , sst and dopamine D2 receptors .", "label": "", "metadata": {}, "score": "53.988167"}
{"text": "Blackhurst G , Strachan MW , Collie D , Gregor A , Statham PFX , Seckl JER : The treatment of a thyrotropin - secreting pituitary macroadenoma with octreotide in twin pregnancy .", "label": "", "metadata": {}, "score": "54.330315"}
{"text": "A test dose of Octreotide ( 50 \u03bc g or 100 \u03bc g ) injected subcutaneously followed by a GH - profile can have some prognostic value [ 99 - 101 ] .", "label": "", "metadata": {}, "score": "54.37194"}
{"text": "In three of these patients preceding long - term tumour growth could be demonstrated , irrespective of the therapy applied .In two patients tumour growth was most probably due to the reexpansion of the adenoma after withdrawal of SRL therapy before initiating Pegvisomant .", "label": "", "metadata": {}, "score": "54.375202"}
{"text": "In a meta - analysis Sandret et al .confirmed the usefulness of adding Cabergoline to SRL in patients with an insufficient effect of SRL therapy .", "label": "", "metadata": {}, "score": "54.463768"}
{"text": "The effect was independent of the cosecretion of PRL [ 159 ] .With IGF-1 concentration as an endpoint , normalisation was observed in 19 patients ( 56 % ) with already relatively low IGF - I concentration on Octreotide LAR monotherapy .", "label": "", "metadata": {}, "score": "54.741722"}
{"text": "Lombardi et al .treated 12 patients resistant to SRL therapy with Quinagolide 150 \u03bc g / d in a prospective , placebo - controlled trial .", "label": "", "metadata": {}, "score": "54.93495"}
{"text": "4 , pp .369 - 376 , 1997 .View at Google Scholar . H. J. Quabbe , \" Treatment of acromegaly by trans - sphenoidal operation , 90-yttrium implantation and bromocriptine : results in 230 patients , \" Clinical Endocrinology , vol .", "label": "", "metadata": {}, "score": "55.027645"}
{"text": "She underwent a left lower lung lobectomy .The histo- pathological examination showed a typical carcinoid tumor without mitotic figures or necrosis and with posi- tive immunohistochemical stains for synaptophysin , neuron - specific enolase , and chromogranin A , as well as strong positive staining for ACTH .", "label": "", "metadata": {}, "score": "55.067665"}
{"text": "The following questions can help you start your discussion .What are the goals of my treatment for my acromegaly ?How does my treatment with Sandostatin \u00ae LAR Depot help me reach these goals ?", "label": "", "metadata": {}, "score": "55.17962"}
{"text": "10 , pp .893 - 900 , 1997 .View at Google Scholar .U.Plockinger , M. Reichel , U. Fett , W. Saeger , and H.-J. Quabbe , \" Preoperative octreotide treatment of growth hormone - secreting and clinically nonfunctioning pituitary macroadenomas : effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy , \" Journal of Clinical Endocrinology and Metabolism , vol . 79 , no .", "label": "", "metadata": {}, "score": "55.185383"}
{"text": "222 - 229 , 2010 .View at Publisher \u00b7 View at Google Scholar .R. Pivonello , M. Galderisi , R. S. Auriemma et al . , \" Treatment with growth hormone receptor antagonist in acromegaly : effect on cardiac structure and performance , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "55.26481"}
{"text": "One of the patients is in remission ; the other achieved successful pregnancy despite suboptimal control of acromegaly .One of the A299V carrier family members was previously diagnosed with a microprolactinoma ; we consider this case to be a phenocopy .", "label": "", "metadata": {}, "score": "55.316254"}
{"text": "Almost three years after surgery , while undergoing octreotide LAR treatment , the patient became pregnant .She refused our recommendation to discontinue octreo- tide LAR therapy during the first trimester , as is routine [ 17].", "label": "", "metadata": {}, "score": "55.39391"}
{"text": "12 , pp .601 - 607 , 1997 .View at Google Scholar \u00b7 View at Scopus .P. Marzullo , D. Ferone , C. Di Somma et al . , \" Efficacy of combined treatment with lanreotide and cabergoline in selected therapy - resistant acromegalic patients , \" Pituitary , vol .", "label": "", "metadata": {}, "score": "55.447258"}
{"text": "72 - 74 , 1996 .View at Google Scholar \u00b7 View at Scopus .T. Abe and D. K. L\u00fcdecke , \" Effects of preoperative octreotide treatment on different subtypes of 90 GH - secreting pituitary adenomas and outcome in one surgical centre , \" European Journal of Endocrinology , vol .", "label": "", "metadata": {}, "score": "55.464516"}
{"text": "Longastatina - LAR .Study Arm ( s ) .Experimental : Octreotide - LAR .Patients will receive every 21 days an injection of octreotide - LAR 30 mg until progression is documented .", "label": "", "metadata": {}, "score": "55.48074"}
{"text": "1044 - 1051 , 1993 .View at Google Scholar \u00b7 View at Scopus .M. Losa , E. Ciccarelli , P. Mortini et al . , \" Effects of octreotide treatment on the proliferation and apoptotic index of GH - secreting pituitary adenomas , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "55.49001"}
{"text": "Only one study was designed to investigate the use of high - dose LAR ( 160 mg every 28 days ) .In this study , objective and hormonal responses in patients with progressive metastatic ileal NET non - responder to standard doses , was significantly elevated .", "label": "", "metadata": {}, "score": "55.584522"}
{"text": "SRL effects on tumour volume are independent of drug formulation .They have been observed with the subcutaneous injections of Octreotide as well as with the slow release preparations .", "label": "", "metadata": {}, "score": "55.659595"}
{"text": "2984 - 2990 , 2008 .View at Publisher \u00b7 View at Google Scholar .Z. G. Mao , Y. H. Zhu , H. L. Tang et al . , \" Preoperative lanreotide treatment in acromegalic patients with macroadenomas increases short - term postoperative cure rates : a prospective , randomised trial , \" European Journal of Endocrinology , vol .", "label": "", "metadata": {}, "score": "55.67676"}
{"text": "Results of somatostatin - receptor scintigraphy do not predict tumour volume reduction [ 103 ] .Effect of Preoperative SRL Treatment on Surgical Outcome Early publications suggested that presurgical therapy improves surgical outcome [ 120 , 121 ] .", "label": "", "metadata": {}, "score": "55.815285"}
{"text": "527 - 532 , 1991 .View at Google Scholar \u00b7 View at Scopus .M. S. M. Ip , K. C. B. Tan , W. C. G. Peh , and K. S. L. Lam , \" Effect of Sandostatin LAR on sleep apnoea in acromegaly : correlation with computerized tomographic cephalometry and hormonal activity , \" Clinical Endocrinology , vol .", "label": "", "metadata": {}, "score": "55.88414"}
{"text": "The relationship between DR expression and the postsurgical response to octreotide - LAR was assessed in 19 of the acromegalic patients .DR3 was not detected .", "label": "", "metadata": {}, "score": "56.10419"}
{"text": "On the other hand Abe and Luedecke saw an improvement especially in invasive adenomas [ 124 ] .However , others could not confirm any advantage of presurgical SRL therapy , neither on short- or long - term postoperative comparisons [ 125 - 127 ] .", "label": "", "metadata": {}, "score": "56.369698"}
{"text": "These results were possibly due to insufficient dose titration of Pegvisomant [ 180 ] .Combination Therapy of Pegvisomant and SRL In consideration of the high costs of Pegvisomant therapy Feenstra et al . investigated the effect of monthly Octreotide LAR treatment in combination with Pegvisomant injected once weekly with a dose of up to 80 mg / week [ 178 ] .", "label": "", "metadata": {}, "score": "56.507347"}
{"text": "Today subcutaneous therapy has been superseded by long - acting preparations .Slow Release Formulations of SRL .The introduction of slow release formulations , Octreotide long - acting repeatable ( LAR ) , Lanreotide slow release ( SR ) , and Lanreotide Autogel makes possible an intramuscular or deep subcutaneous injection every 2 - 6 weeks ( Table 1 ) .", "label": "", "metadata": {}, "score": "56.562527"}
{"text": "11 , pp .4519 - 4524 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . U.Pl\u00f6ckinger , S. Albrecht , C. Mawrin et al . , \" Selective loss of somatostatin receptor 2 in octreotide - resistant growth hormone - secreting adenomas , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "56.56458"}
{"text": "This paper outlines the present status of medical therapy of acromegaly .Indications for permanent postoperative treatment , postirradiation treamtent to bridge the interval until remission as well as primary medical therapy are elaborated .", "label": "", "metadata": {}, "score": "56.575104"}
{"text": "6 , pp .941 - 943 , 1972 .View at Google Scholar .R. Abs , J. Verhelst , D. Maiter et al . , \" Cabergoline in the treatment of acromegaly : a study in 64 patients , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "56.758034"}
{"text": "6 , pp .1443 - 1445 , 1989 .View at Google Scholar \u00b7 View at Scopus .J. S. Bevan , \" The antitumoral effects of somatostatin analog therapy in acromegaly , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "56.98751"}
{"text": "J Clin Endocrinol Metab 2005 , 90:4955 - 4962 .Naccache et al .Page 5 .Deb SJ , Nichols FC , Allen MS , Deschamps C , Cassivi SD , Pairolero PC : Pulmonary carcinoid tumors with Cushing 's syndrome : an aggressive variant or not ?", "label": "", "metadata": {}, "score": "57.020782"}
{"text": "669 - 692 , 1992 .View at Google Scholar .G. T. Tindall , N. M. Oyesiku , N. B. Watts , R. V. Clark , J. H. Christy , and D. A. Adams , \" Transsphenoidal adenomectomy for growth hormone - secreting pituitary adenomas in acromegaly : outcome analysis and determinants of failure , \" Journal of Neurosurgery , vol .", "label": "", "metadata": {}, "score": "57.022316"}
{"text": "6 , pp .2789 - 2796 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. U. Freda , L. Katznelson , A. J. Van Der Lely , C. M. Reyes , S. Zhao , and D. Rabinowitz , \" Long - acting somatostatin analog therapy of acromegaly : a meta - analysis , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "57.2275"}
{"text": "4 , pp .477 - 478 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. Selvarajah , J. Webster , R. Ross , and J. Newell - Price , \" Effectiveness of adding dopamine agonist therapy to long - acting somatostatin analogues in the management of acromegaly , \" European Journal of Endocrinology , vol .", "label": "", "metadata": {}, "score": "57.31473"}
{"text": "BACKGROUND : Somatostatin analogs previously considered as adjuvant therapy in acromegaly are increasingly used as a first - line therapy in selected cases .OBJECTIVE :", "label": "", "metadata": {}, "score": "57.494698"}
{"text": "Moreover , patients with a microadenoma will probably not profit from presurgical SRL treatment , while those with large macroadenomas may benefit [ 24 , 61 ] .", "label": "", "metadata": {}, "score": "57.496544"}
{"text": "View at Publisher \u00b7 View at Google Scholar .J. Ayuk , S. E. Stewart , P. M. Stewart , and M. C. Sheppard , \" Long - term safety and efficacy of depot long - acting somatostatin analogs for the treatment of acromegaly , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "57.591835"}
{"text": "33 - 38 , 2011 .View at Publisher \u00b7 View at Google Scholar .I. Bernabeu , C. Alvarez - Escol\u00e1 , C. Quinteiro et al . , \" The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegaly , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "57.718117"}
{"text": "59 - 63 , 1994 .View at Google Scholar \u00b7 View at Scopus .P. Jaquet , \" CV 205 - 502 : a more effective dopamine agonist m the treatment of acromegaly ? \" European Journal of Endocrinology , vol .", "label": "", "metadata": {}, "score": "57.748215"}
{"text": "477 - 486 , 2001 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .I. Shimon , T. Rubinek , M. Hadani , and N. Alhadef , \" PTR-3173 ( Somatoprim ) , a novel somatostatin analog with affinity for somatostatin receptors 2 , 4 and 5 is a potent inhibitor of human GH secretion , \" Journal of Endocrinological Investigation , vol .", "label": "", "metadata": {}, "score": "57.759796"}
{"text": "Recruiting Status : Enrollment is open .An acromegaly , open - label , multi - center , safety monitoring program for treating patients with SOM230 ( pasireotide ) LAR , who have need to receive medical therapy ( ACCESS ) .", "label": "", "metadata": {}, "score": "57.799774"}
{"text": "Validating the presence of sst2 and sst5 on adenoma tissue has been suggested to allow the prediction of clinical efficacy of SRL .However immunohistochemical application for in vitro diagnostic has been hampered due to the lack of monoclonal and specific polyclonal anti - sst2 and sst5 antibodies .", "label": "", "metadata": {}, "score": "57.844196"}
{"text": "10 , pp .1837 - 1844 , 2005 .View at Publisher \u00b7 View at Google Scholar .S. J. C. M. M. Neggers , M. O. Van Aken , W. W. De Herder et al . , \" Quality of life in acromegalic patients during long - term somatostatin analog treatment with and without pegvisomant , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "58.086212"}
{"text": "Caron P , Gerbeau C , Pradayrol L : Maternal - fetal transfer of octreotide .N Engl J Med 1995 , 333:601 - 602 .", "label": "", "metadata": {}, "score": "58.124523"}
{"text": "Thus , using these highly sensitive tools may allow the prediction of an adenoma 's response to SRL and even the selection of receptor - specific SRL .", "label": "", "metadata": {}, "score": "58.22779"}
{"text": "Determine mean GH value of 5 blood samples collected 30 min apart for 2 consecutive hours in the follow - up of acromegalic patients treated with octreotide LAR .", "label": "", "metadata": {}, "score": "58.293392"}
{"text": "255 - 264 , 2011 .View at Publisher \u00b7 View at Google Scholar .T. Fischer , C. Doll , S. Jacobs , A. Kolodziej , R. Stumm , and S. Schulz , \" Reassessment of sst2 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-1 , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "58.389397"}
{"text": "No previous studies have been undertaken to evaluate the SSTR and DR profile related with the gsp status in somatotropinomas .To determine if ( 1 ) gsp status is correlated with response to octreotide LAR ( LAR ) and tumor expression patterns of SSTR1 - 5 and DR1 - 5 and ( 2 ) cAMP level can directly modulate SSTR and DR mRNA levels .", "label": "", "metadata": {}, "score": "58.443268"}
{"text": "Immunohistochemically SRL treatment induced a lower expression of Ki-67 staining , an indicator of dividing cells , compared to untreated somatotropinomas .The lower Ki-67 index indicates a suppressive effect of SRL on cell cycling [ 113 ] .", "label": "", "metadata": {}, "score": "58.454834"}
{"text": "6 , pp .829 - 835 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. C. De Martino , R. S. Auriemma , G. Brevetti et al . , \" The treatment with growth hormone receptor antagonist in acromegaly : effect on vascular structure and function in patients resistant to somatostatin analogues , \" Journal of Endocrinological Investigation , vol .", "label": "", "metadata": {}, "score": "58.60845"}
{"text": "1856 - 1863 , 2005 .View at Publisher \u00b7 View at Google Scholar .R. Cozzi , R. Attanasio , M. Montini et al . , \" Four - year treatment with octreotide - long - acting repeatable in 110 acromegalic patients : predictive value of short - term results ? \"", "label": "", "metadata": {}, "score": "58.784798"}
{"text": "However , when preliminary in vitro results were followed by a \" proof - of - principle \" clinical trial the results failed to show any additional effect of this chimeric molecule on GH secretion .", "label": "", "metadata": {}, "score": "58.839394"}
{"text": "It has been demonstrated that combined therapy with SRL is almost as effective as Pegvisomant monotherapy , but can be substantially more cost - effective .", "label": "", "metadata": {}, "score": "58.87391"}
{"text": "Introduction .Surgical therapy of acromegaly aims for elimination of the tumour and normalisation of both , growth hormone ( GH ) secretion and Insulin - like growth factor-1 ( IGF-1 ) concentration .", "label": "", "metadata": {}, "score": "58.87691"}
{"text": "10 , pp .1506 - 1509 , 1999 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Colao , P. Marzullo , D. Ferone et al . , \" Prostatic hyperplasia : an unknown feature of acromegaly , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "58.920715"}
{"text": "Avidity of octreotide to somatostatin receptor sub - type 2 was later confirmed by a positive somatostatin receptor sub - type 2 in the resected tumor specimen .", "label": "", "metadata": {}, "score": "58.96212"}
{"text": "4 , pp .843 - 849 , 2000 .View at Google Scholar .C. Bruns , I. Lewis , U. Briner , G. Meno - Tetang , and G. Weckbecker , \" SOM230 : a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor ( SRIF ) receptor binding and a unique antisecretory profile , \" European Journal of Endocrinology , vol .", "label": "", "metadata": {}, "score": "59.109528"}
{"text": "However , highly sensitive assays demonstrated active acromegaly with a GH nadir during OGTT well below 1 \u03bc g / L. Freda et al . reported that five of fifteen newly diagnosed acromegalic patients reached a GH nadir during OGTT below 1 \u03bc g / L , even as low as 0.42 \u03bc g / L. The IGF-1 concentration was elevated in all patients , but signs and symptoms of acromegaly were subtle in three patients .", "label": "", "metadata": {}, "score": "59.448883"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : To determine whether the somatostatin receptor subtype ( SSTR ) expression profile correlates with hormonal and tumor volume responses to postsurgical octreotide long acting repeatable ( OCT LAR ) treatment .", "label": "", "metadata": {}, "score": "59.482048"}
{"text": "Bevan , in a careful review , found contradictory reports with respect to the positive correlation of pretreatment tumour volume and response to SRL .Tumour shrinkage does occur in both , macro- and microadenomas [ 117 ] .", "label": "", "metadata": {}, "score": "59.58273"}
{"text": "Sst5 was seen in all , sst2 in 83 % to 85 % of the somatotropinomas .However , interindividual variability in the percentage of positive cells and the intensity of staining was pronounced [ 63 - 65 ] .", "label": "", "metadata": {}, "score": "59.741634"}
{"text": "Thus determination of the GH concentration during Pegvisomant with an assay that does not crossreact with the drug might identify those patients at risk for tumour growth .", "label": "", "metadata": {}, "score": "59.85059"}
{"text": "Janson ET , Stridsberg M , Gobl A , Westlin JE , Oberg K : Determination of somatostatin receptor subtype 2 in carcinoid tumors by immunohistochemical investigation with somatostatin receptor subtype 2 antibodies .", "label": "", "metadata": {}, "score": "59.85405"}
{"text": "In addition , we determined whether the level of DR expression correlates with the in vivo response to octreotide - LAR in acromegalic patients .Eight NPs , 30 NFPAs , and 39 somatotropinomas were analyzed for receptor mRNA levels by real - time RT - PCR .", "label": "", "metadata": {}, "score": "60.093407"}
{"text": "It would , however , be compatible with the good response to DA treatment in monohormonal prolactinomas .Cabergoline Cabergoline is more effective than Bromocriptine , Methysergid , or Lisurid .", "label": "", "metadata": {}, "score": "60.182507"}
{"text": "We also evaluated the safety and efficacy of transsphenoidal surgery ( TSS ) in this patient group .During the 28-year period from 1980 to 2007 we treated 290 patients with acromegaly at our hospitals .", "label": "", "metadata": {}, "score": "60.33944"}
{"text": "The relative role of treatment options is still matter of debate .METHODS : A retrospective chart review was performed on all the acromegalic patients attending our center along the last ... .", "label": "", "metadata": {}, "score": "60.43708"}
{"text": "287 - 317 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. Trepp , R. Everts , C. Stettler et al . , \" Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the acromegaly quality of life questionnaire ( AcroQoL ) , \" Clinical Endocrinology , vol .", "label": "", "metadata": {}, "score": "60.49533"}
{"text": "Growth hormone during acute test with subcutaneous octreotide decreased from 112 to 7 ng / mL. Octreotide LAR \u00ae therapy ( 20 mg q28 days ) was then initiated .", "label": "", "metadata": {}, "score": "60.5449"}
{"text": "Objective : To assess the effect of GHR on tumour recurrence in patients with NFAs solely ... .BACKGROUND :Data on surgical and medical treatment outcomes in acromegaly mostly originate from specialized centers .", "label": "", "metadata": {}, "score": "60.595867"}
{"text": "Preview \u00b7 Article \u00b7 Dec 2008 \u00b7 Arquivos brasileiros de endocrinologia e metabologia .The prevalence of discordance in acromegalics has been described to vary from 9.4 % to 39 % , and it may be observed at diagnosis or during the follow up .", "label": "", "metadata": {}, "score": "60.682625"}
{"text": "The aim of this study is to evaluate the serum cortisol responses to desmopressin after pituitary surgery , establishing an optimal cut - off for absolute increment ... .", "label": "", "metadata": {}, "score": "60.80158"}
{"text": "Molecular analysis of tumor fragments : gsp + ; quantitative analysis of SSTR ( somatostatin receptor ) and DR ( dopamine receptor ) mRNA - SSTR2 23954 ; SSTR5 2407 ; DR2 total 17016 copies .", "label": "", "metadata": {}, "score": "60.811417"}
{"text": "Molecular analysis of tumor fragments : gsp + ; quantitative analysis of SSTR ( somatostatin receptor ) and DR ( dopamine receptor ) mRNA - SSTR2 23954 ; SSTR5 2407 ; DR2 total 17016 copies .", "label": "", "metadata": {}, "score": "60.811417"}
{"text": "4 , pp .371 - 376 , 2011 .View at Publisher \u00b7 View at Google Scholar .M. Buchfelder , S. Schlaffer , M. Droste et al . , \" The German ACROSTUDY : past and present , \" European Journal of Endocrinology , vol .", "label": "", "metadata": {}, "score": "60.9095"}
{"text": "Molecular analysis of tumor fragments : gsp not done ; quantitative analysis of SSTR and DR mRNA - SSTR2 416 ; SSTR5 3767 ; DR2 total 3439 copies .", "label": "", "metadata": {}, "score": "61.05366"}
{"text": "Molecular analysis of tumor fragments : gsp not done ; quantitative analysis of SSTR and DR mRNA - SSTR2 416 ; SSTR5 3767 ; DR2 total 3439 copies .", "label": "", "metadata": {}, "score": "61.05366"}
{"text": "Tumour Shrinkage SRL reduce tumour volume in about 50 % of previously untreated acromegalic patients .The extent of tumour shrinkage in these patients has been reported to be as high an 50 % .", "label": "", "metadata": {}, "score": "61.09541"}
{"text": "While some authors found that the decline of GH and/or IGF-1 concentration predicted tumour shrinkage in therapy naive patients , other could not demonstrate a correlation between biochemical efficacy and tumour shrinkage [ 117 ] .", "label": "", "metadata": {}, "score": "61.116364"}
{"text": "The response to LAR did not significantly differ between patients with gsp+ and gsp- tumors ; however , gsp+ tumors expressed higher levels of SSTR1 , SSTR2 , DR2 and a lower level of SSTR3 .", "label": "", "metadata": {}, "score": "61.287643"}
{"text": "4 , pp .661 - 666 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Colao , \" The importance of presurgical somatostatin analogue therapy in acromegaly , \" Endokrynologia Polska , vol .", "label": "", "metadata": {}, "score": "61.355713"}
{"text": "The samples taken from the lymph node metastases were inadequate for SSTR immunohistochemistry .Naccache et al .Page 3 . normal growth patterns during 128 months of follow - up ( Figure 1 ) .", "label": "", "metadata": {}, "score": "61.388115"}
{"text": "Evaluation of Remission Criteria .Whether failure to achieve these criteria for complete remission of acromegaly is identical to the indication for medical therapy is still a matter of debate .", "label": "", "metadata": {}, "score": "61.515205"}
{"text": "In the following a short overview on the indications for medical therapy in acromegaly will be given .The different available forms of medical therapy will be treated in detail .", "label": "", "metadata": {}, "score": "61.606895"}
{"text": "In comparison with normal pituitary tissue , somatotroph adenomas are characterized by a higher density of sst2 and sst5 .The expression of sst in adenoma tissue is inhomogeneous and tumour specific .", "label": "", "metadata": {}, "score": "61.707756"}
{"text": "2 - 44 , 2011 .View at Google Scholar .P. Nomikos , M. Buchfelder , and R. Fahlbusch , \" The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical ' cure ' , \" European Journal of Endocrinology , vol .", "label": "", "metadata": {}, "score": "61.725216"}
{"text": "On the other hand , it has to be remarked that long - acting SSA are being used in NET patients at doses correspondent to the low doses of short - acting formulation .", "label": "", "metadata": {}, "score": "61.777973"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. Ezzat , P. J. Snyder , W. F. Young et al . , \" Octreotide treatment of acromegaly : a randomized , multicenter study , \" Annals of Internal Medicine , vol .", "label": "", "metadata": {}, "score": "61.783886"}
{"text": "Third , it supports the correla- tion between a good response to somatostatin analogue therapy and the presence of SSTR2 in the diseased tar- get tissue .", "label": "", "metadata": {}, "score": "61.814774"}
{"text": "Questions to Ask Your Doctor About Acromegaly and Sandostatin \u00ae ( octreotide acetate ) .If you have been diagnosed with acromegaly , your doctor may have determined that Sandostatin \u00ae LAR Depot ( octreotide acetate for injectable suspension ) is the right treatment for you .", "label": "", "metadata": {}, "score": "61.92987"}
{"text": "No systematic studies were performed with the commercially available long - acting SSA used in high - dose treatments .In patients with progressive locally advanced or metastatic NET , increase of the dose or reduction of the interval between injections is a relatively common \" empirical \" clinical practice , but no studies have been performed to evaluate safety and efficacy of this treatment schedule .", "label": "", "metadata": {}, "score": "62.0121"}
{"text": "87 , no . 7 , pp .3142 - 3147 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . E. V. Dimaraki , C. A. Jaffe , R. Demott - Friberg , W. F. Chandler , and A. L. Barkan , \" Acromegaly with apparently normal GH secretion : implications for diagnosis and follow - up , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "62.231335"}
{"text": "5 , pp .707 - 716 , 2002 .View at Google Scholar \u00b7 View at Scopus .G. Weckbecker , U. Briner , I. Lewis , and C. Bruns , \" SOM230 : a new somatostatin peptidomimetic with potent inhibitory effects on the growth hormone / insulin - like growth factor - I axis in rats , primates , and dogs , \" Endocrinology , vol .", "label": "", "metadata": {}, "score": "62.251957"}
{"text": "( A ) Body length .( B ) Head circumference .( C ) Body weight .Naccache et al .Page 4 . during the last part of pregnancy were reported in a woman with a TSH - producing pituitary adenoma who was undergoing octreotide treatment at the time [ 15].", "label": "", "metadata": {}, "score": "62.263348"}
{"text": "Hearn PR , Reynolds CL , Johansen K , Woodhouse NJY : Lung carcinoid with Cushing 's syndrome : control of serum ACTH and cortisol levels using SMS 201 - 995 ( Sandostatin ) .", "label": "", "metadata": {}, "score": "62.27934"}
{"text": "In contrast , SSTR3 mRNA was present at the highest level in NFPA , followed by SSTR2 , while SSTR1 , SSTR4 , and SSTR5 transcripts were only detectable in select tumors .", "label": "", "metadata": {}, "score": "62.43509"}
{"text": "Colao AM , Merola , Ferone D , Lombardi G : Acromegaly .J Clin Endocrinol Metab 1997 , 82:2777 - 2781 .Mikhail N : Octreotide treatment of acromegaly during pregnancy .", "label": "", "metadata": {}, "score": "62.438454"}
{"text": "21 - 30 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Colao , D. Ferone , P. Marzullo et al . , \" Effect of different dopaminergic agents in the treatment of acromegaly , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "62.456978"}
{"text": "An indium-111 pentetreotide scan obtained to locate an occult focus of the carcinoid revealed a hot focus in the left lower pulmonary lobe and the upper right mediasti- num .", "label": "", "metadata": {}, "score": "62.481655"}
{"text": "3746 - 3756 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. D. Murray and S. Melmed , \" A critical analysis of clinically available somatostatin analog formulations for therapy of acromegaly , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "62.48558"}
{"text": "To dissolve gallbladder sludge , both chenodeoxycholic acid and ursodeoxycholic acid are highly efficient .Immediately after the conclusion of subcutaneous Octreotide therapy a short - lived hyperactive gallbladder contraction can be observed .", "label": "", "metadata": {}, "score": "62.642403"}
{"text": "So far five different human somatostatin receptor subtypes , sst1 , sst2A , sst3 - 5 , are known .Binding of somatostatin to sst results in a G - protein - coupled activation of adenylate - cyclase .", "label": "", "metadata": {}, "score": "62.681282"}
{"text": "209 - 215 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .B. Gatta , D. H. Hau , B. Catargi , P. Roger , and A. Tabarin , \" Re - evaluation of the efficacy of the association of cabergoline to somatostatin analogues in acromegalic patients , \" Clinical Endocrinology , vol .", "label": "", "metadata": {}, "score": "62.68451"}
{"text": "Aubry MC , Thomas CF Jr , Jett JR , Swensen SJ , Myers JL : Significance of multiple carcinoid tumors and tumorlets in surgical lung specimens : analysis of 28 patients .", "label": "", "metadata": {}, "score": "62.726036"}
{"text": "METHOD : ... .In the early postoperative period of Cushing 's disease patients , desmopressin may stimulate ACTH secretion in the remnant corticotrophic tumour , but not in nontumour suppressed cells .", "label": "", "metadata": {}, "score": "62.77948"}
{"text": "last dose and 3 months after pasireotide LAR last dose Highly effective contraception methods include : .Total abstinence ( when this is in line with the preferred and usual lifestyle of the subject .", "label": "", "metadata": {}, "score": "62.803932"}
{"text": "We analyzed the safety and efficacy of SR in patients who had previously received maximal surgical debulking at our center .DESIGN :The study was a retrospective analysis of hormonal , radiological , and ophthalmologic data collected in a ... .", "label": "", "metadata": {}, "score": "62.809376"}
{"text": "These uncertainties render the role of IGF-1 or the GH nadir during OGTT as the sole parameter for the estimation of prognosis ( recurrence , morbidity , and mortality ) of acromegaly problematic [ 10 , 46 , 47 ] .", "label": "", "metadata": {}, "score": "62.81322"}
{"text": "Thus quality of life evaluation may offer additional clues with respect to treatment indications .The lack of correlation between QoL and biochemical markers of the disease does not come as a surprise , as duration of the disease , extent of physical disfigurement , and comorbidities may have additional and individual impacts on the quality of life with acromegaly .", "label": "", "metadata": {}, "score": "62.875065"}
{"text": "289 - 297 , 1980 .View at Google Scholar .R. Barrie , E. A. Woltering , H. Hajarizadeh , C. Mueller , T. Ure , and W. S. Fletcher , \" Inhibition of angiogenesis by somatostatin and somatostatin - like compounds is structurally dependent , \" Journal of Surgical Research , vol .", "label": "", "metadata": {}, "score": "62.906715"}
{"text": "5 , pp .389 - 393 , 1993 .View at Google Scholar .T. Svoboda , H. Kotzmann , M. Clodi , P. Bernecker , G. Geyer , and A. Luger , \" The non ergot D2-dopamine agonist cv 205 - 502 decreases growth hormone concentrations in acromegalic patients , \" Endocrine Research , vol .", "label": "", "metadata": {}, "score": "62.91188"}
{"text": "Mediastinal and paratracheal histopathology of lymph node material obtained by performing a thoracoscopy showed a metastatic carcinoid .Following treatment with octreotide LAR 30 mg / month , she became symptom - free .", "label": "", "metadata": {}, "score": "62.914845"}
{"text": "In most of these cases surgery will fail to cure the patient .While surgery aims to remove all adenoma tissue , primary medical therapy tries to achieve biochemical remission , prevention of tumour growth , and possibly tumour volume reduction .", "label": "", "metadata": {}, "score": "63.197647"}
{"text": "We reviewed our experience with micronodular adrenal hyperplasia ( MAH ) , its pigmented variant primary pigmented nodular adrenocortical disease ( PPNAD ) , and the association with Carney 's complex ( CNC ) to better characterize these disorders .", "label": "", "metadata": {}, "score": "63.334595"}
{"text": "Isidori AM , Kaltsas GA , Pozza C , Frajese V , Newell - Price J , Reznek RH , Jenkins PJ , Monson JP , Grossman AB , Besser GM : The ectopic adrenocorticotropin syndrome : clinical features , diagnosis , management , and long - term follow - up .", "label": "", "metadata": {}, "score": "63.572365"}
{"text": "These data reinforce the discussion about the concept of \" extra - hepatic acromegaly \" [ 173 ] and the resulting need for new biomarkers for the evaluation of therapeutic efficacy in acromegaly .", "label": "", "metadata": {}, "score": "63.903828"}
{"text": "4 , pp .1203 - 1210 , 2008 .View at Publisher \u00b7 View at Google Scholar .M. Pfeiffer , T. Koch , H. Schr\u00f6der et al . , \" Homo- and heterodimerization of somatostatin receptor subtypes .", "label": "", "metadata": {}, "score": "63.967194"}
{"text": "Elevated SSTR1 , SSTR2 , and DR2 tumor expression may help improve responsiveness to SA and DA therapy ; however , this study may not have been appropriately powered to observe significant effects in the clinical response .", "label": "", "metadata": {}, "score": "63.97688"}
{"text": "Thus sst2A - sst3 heterodimerisation resulted in a new receptor with enhanced sst2A - like and diminished sst3-like activity [ 67 ] .Grant and Kumar demonstrated that sst2 and sst5 form heterodimers upon subtype - specific sst2 ligand activation [ 68 ] .", "label": "", "metadata": {}, "score": "63.98448"}
{"text": "89 - 98 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Liuzzi , P. G. Chiodini , L. Botalla , G. Cremascoli , and F. Silvestrini , \" Inhibitory effect of L - Dopa on GH release in acromegalic patients , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "64.0011"}
{"text": "S15-S20 , 2003 .View at Google Scholar \u00b7 View at Scopus . A. N. Paisley , K. Hayden , A. Ellis , J. Anderson , G. Wieringa , and P. J. Trainer , \" Pegvisomant interference in GH assays results in underestimation og GH levels , \" European Journal of Endocrinology , vol .", "label": "", "metadata": {}, "score": "64.022316"}
{"text": "Finally , an algorithm for the medical treatment of acromegaly will be proposed .Indication for Medical Therapy .A high GH- and IGF-1 concentration persisting after incomplete surgery or prevailing in the first years after irradiation is a clear indication for medical therapy .", "label": "", "metadata": {}, "score": "64.08421"}
{"text": "Response to OCT LAR was studied by hormone levels ( GH and IGF - I ) and tumor volume ( sella turcica magnetic resonance imaging ) .", "label": "", "metadata": {}, "score": "64.11157"}
{"text": "Growth hormone during acute test with subcutaneous octreotide decreased from 112 to 7 ng / mL. Octreotide LAR therapy ( 20 mg q28 days ) was then initiated .", "label": "", "metadata": {}, "score": "64.11836"}
{"text": "Thus it is important to shortly review the problems of diagnosing persistent acromegaly in patients with a relatively low GH concentration after pituitary surgery and relating them to the commonly accepted remission criteria .", "label": "", "metadata": {}, "score": "64.15184"}
{"text": "Hence , such assessment is presently dependent on case reports .Ectopic adrenocorticotropic hormone ( ACTH)- dependent Cushing 's syndrome associated with bron- chial carcinoid is well recognized .", "label": "", "metadata": {}, "score": "64.3107"}
{"text": "55 - 61 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. Bonadonna , G. Mazziotti , M. Nuzzo et al . , \" Increased prevalence of radiological spinal deformities in active acromegaly : a cross - sectional study in postmenopausal women , \" Journal of Bone and Mineral Research , vol .", "label": "", "metadata": {}, "score": "64.41956"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. P. Matta , E. Couture , L. Cazals , D. Vezzosi , A. Bennet , and P. Caron , \" Impaired quality of life of patients with acromegaly : control of GH / IGF - I excess improves psychological subscale appearance , \" European Journal of Endocrinology , vol .", "label": "", "metadata": {}, "score": "64.479195"}
{"text": "Warnings and Precautions : Treatment with Sandostatin LAR Depot may affect gallbladder function , sugar metabolism , thyroid and heart function , and nutritional absorption , which may require monitoring by your doctor .", "label": "", "metadata": {}, "score": "64.48786"}
{"text": "2730 - 2734 , 1998 .View at Publisher \u00b7 View at Google Scholar .S. M. Webb , L. Prieto , X. Badia et al . , \" Acromegaly Quality of Life Questionnaire ( ACROQOL ) a new health - related quality of life questionnaire for patients with acromegaly : development and psychometric properties , \" Clinical Endocrinology , vol .", "label": "", "metadata": {}, "score": "64.525"}
{"text": "2459 - 2463 , 2009 .View at Publisher \u00b7 View at Google Scholar .C. Jimenez , M. Ayala - Ramirez , J. Liu , R. Nunez , and R. F. Gagel , \" Inhibition of growth hormone receptor activation by pegvisomant may increase bone density in acromegaly , \" Hormone and Metabolic Research , vol .", "label": "", "metadata": {}, "score": "64.5369"}
{"text": "2147 - 2154 , 2010 .View at Publisher \u00b7 View at Google Scholar . D. Buyuktas , O. Celik , F. Kantarci , and P. Kadioglu , \" Lipodystrophy during pegvisomant therapy : a case report and review of the literature , \" Clinics , vol .", "label": "", "metadata": {}, "score": "64.54129"}
{"text": "The change in the IGF - I concentration was significantly related to the baseline IGF - I concentration but not to the dose of Cabergoline , the duration of treatment , or the baseline prolactin concentration [ 151 ] .", "label": "", "metadata": {}, "score": "64.62756"}
{"text": "Veldhuis et al .demonstrated , based upon CSF measurements , that the pegylated GH - receptor antagonist does not cross the human blood - brain barrier [ 172 ] .", "label": "", "metadata": {}, "score": "64.76561"}
{"text": "61 - 62 , 1996 .View at Google Scholar \u00b7 View at Scopus . A. Colao , R. S. Auriemma , M. Galdiero et al . , \" Impact of somatostatin analogs versus surgery on glucose metabolism in acromegaly : results of a 5-year observational , open , prospective study , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "64.96324"}
{"text": "For this reason , the decision as to a treatment modality of acromegaly must be followed by a thorough evaluation of the patient and once the diagnosis of complications is settled , adequate treatment should be instituted .", "label": "", "metadata": {}, "score": "65.02571"}
{"text": "6 , pp .2779 - 2786 , 2001 .View at Publisher \u00b7 View at Google Scholar . A. L. Barkan , R. V. Lloyd , W. F. Chandler et al . , \" Preoperative treatment of acromegaly with long - acting somatostatin analog SMS 201 - 995 : shrinkage of invasive pituitary macroadenomas and improved surgical remission rate , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "65.04567"}
{"text": "To implement and assess a protocol for reduced glucocorticoid ... .In particular , preoperative diagnosis , ... .BACKGROUND : Acromegaly is a chronic disease impacting on morbidity and mortality .", "label": "", "metadata": {}, "score": "65.11581"}
{"text": "Differing provisions from the publisher 's actual policy or licence agreement may be applicable .[ Show abstract ] [ Hide abstract ] ABSTRACT : Context : Germline AIP mutations usually cause young - onset acromegaly with low penetrance in a subset of familial isolated pituitary adenoma families .", "label": "", "metadata": {}, "score": "65.1833"}
{"text": "10 , pp .3853 - 3859 , 2008 .View at Publisher \u00b7 View at Google Scholar .M. Buchfelder , D. Weigel , M. Droste et al . , \" Pituitary tumor size in acromegaly during pegvisomant treatment : experience from MR re - evaluations of the German Pegvisomant Observational Study , \" European Journal of Endocrinology , vol .", "label": "", "metadata": {}, "score": "65.1887"}
{"text": "There was no benefit to perform GH curves with the present protocol .It may be due to our established outpatient follow up protocol .The use of more complex protocols and the cost of multiple GH assays should be acknowledged , and probably reserved for patients with basal GH levels between 1 and 5 microg / L with discordant GH and IGF - I. [ Show abstract ] [ Hide abstract ] ABSTRACT : Ectopic growth hormone - releasing hormone ( GHRH)-secreting tumors are rare and cause acromegaly with somatotroph hyperplasia .", "label": "", "metadata": {}, "score": "65.19499"}
{"text": "Eliza B. Geer , MD , is the principal investigator for the above studies .Clinical Trials .A randomized , double - blind , multi - center , phase III study to evaluate the efficacy and safety of pasireotide LAR in patients with Cushing 's disease .", "label": "", "metadata": {}, "score": "65.212036"}
{"text": "We observed a prevalence of discordance similar to that previously described in the literature .We believe that studies evaluating morbidity and mortality in discordant patients are also necessary and will enlighten the true impact of this condition in the follow up of acromegaly .", "label": "", "metadata": {}, "score": "65.21683"}
{"text": "The addition of dopamine agonists resulted in a further decline of the GH and IGF-1 concentration not achieved by SRL treatment alone [ 158 ] .", "label": "", "metadata": {}, "score": "65.24368"}
{"text": "Colao et al .compared the effect of Bromocriptine , Cabergoline , and Quinagolide in 34 acromegalic patients .They concluded that both , Cabergoline and Bromocriptine ( given as a LAR preparation ) , can not be considered useful medical approaches for acromegaly , whereas Quinagolide normalised circulating GH and IGF - I levels in 47.8 % of patients [ 150 ] .", "label": "", "metadata": {}, "score": "65.30444"}
{"text": "107 - 119 , 1982 .View at Google Scholar \u00b7 View at Scopus .R. Fahlbusch , J. Honegger , and M. Buchfelder , \" Surgical management of acromegaly , \" Endocrinology and Metabolism Clinics of North America , vol .", "label": "", "metadata": {}, "score": "65.311615"}
{"text": "4 , pp .555 - 559 , 2011 .View at Publisher \u00b7 View at Google Scholar .G. Brabant , A. Von Zur M\u00fchlen , C. W\u00fcster et al . , \" Serum insulin - like growth factor I reference values for an automated chemiluminescence immunoassay system : results from a multicenter study , \" Hormone Research , vol .", "label": "", "metadata": {}, "score": "65.34013"}
{"text": "Surgical biopsy revealed a well - differentiated follicular carcinoma of the thyroid .Whole - body I131 scan revealed intense fixation of radioactive material in the lesion .", "label": "", "metadata": {}, "score": "65.47647"}
{"text": "Somatostatin inhibits angiogenesis either directly or via growth factors , that is , vascular endothelial growth factor ( VEGF ) , basic fibroblast growth factor ( bFGF ) , and IGF-1 or through its immunomodulatory effects [ 69 ] .", "label": "", "metadata": {}, "score": "65.49537"}
{"text": "538 - 544 , 1999 .View at Publisher \u00b7 View at Google Scholar . H. J. Quabbe and U. Pl\u00f6ckinger , \" Metabolic aspects of acromegaly and its treatment , \" Metabolism : Clinical and Experimental , vol .", "label": "", "metadata": {}, "score": "65.709724"}
{"text": "An immunohistochemistry assay was performed to determine the somatostatin receptor ( SSTR ) sub - types in the tissue of the original carcinoid in the lung lobe as previously described [ 18].", "label": "", "metadata": {}, "score": "65.717224"}
{"text": "In a Belgian multicentre trial with 64 acromegalic patients receiving Cabergoline 1 - 1.75 mg / d once weekly , the IGF-1 concentration declined to below 300 \u03bc g / L in 8 of 16 ( 50 % ) patients with GH / PRL cosecretion and in 39 % of the whole group .", "label": "", "metadata": {}, "score": "65.72529"}
{"text": "In contrast , in another study referred to by the authors , this dose , given as monotherapy , resulted in normalisation of the IGF-1 concentration only in about one third of the patients .", "label": "", "metadata": {}, "score": "65.76503"}
{"text": "( subtypes 2 and 5 ) and the dopamine D2 receptor [ 144 - 146 ] .A substantial number of somatotroph adenomas express both sst and D2 receptors .", "label": "", "metadata": {}, "score": "65.776886"}
{"text": "A ROC curve analysis showed a SSTR2/SSTR5 ratio of 1.3 as the best predictor of disease control , with a sensitivity of 88 % and a specificity of 92 % - area under curve , 0.9 .", "label": "", "metadata": {}, "score": "65.77726"}
{"text": "379 - 387 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. De , D. A. Rees , N. Davies et al . , \" Transsphenoidal surgery for acromegaly in Wales : results based on stringent criteria of remission , \" Journal of Clinical Endocrinology and Metabolism , vol . 88 , no . 8 , pp .", "label": "", "metadata": {}, "score": "65.788055"}
{"text": "Characterization of Treatment and Outcomes in Patients with Prolactinomas .This is an ongoing database and long - term follow up study of patients with prolactinomas .", "label": "", "metadata": {}, "score": "66.100845"}
{"text": "The volume increase was considered clinically irrelevant and Pegvisomant therapy was continued .In six of the eight patients with tumour growth , the GH concentration could be determined by a specific assay excluding cross - reaction with Pegvisomant .", "label": "", "metadata": {}, "score": "66.108"}
{"text": "Acromegaly was then suspected to be due to ectopic secretion of GHRH by the tumor .Patient underwent surgical resection and histopathologic examination confirmed a pheochromocytoma which stained positively for GHRH .", "label": "", "metadata": {}, "score": "66.1173"}
{"text": "( only patients receiving pasireotide monotherapy can be included ) .Pregnant or nursing ( lactating ) women , where pregnancy is defined as the state of a female after conception and until the termination of gestation , confirmed by a positive hCG laboratory test .", "label": "", "metadata": {}, "score": "66.181305"}
{"text": "528 - 537 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Colao , R. S. Auriemma , S. Savastano et al . , \" Glucose tolerance and somatostatin analog treatment in acromegaly : a 12-month study , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "66.22557"}
{"text": "In retrospective analyses of long - term outcome in acromegaly a normal IGF-1 concentration correlated positively with a normal survival of the patients [ 14 , 23 , 51 , 52 ] .", "label": "", "metadata": {}, "score": "66.22641"}
{"text": "In somatotropinomas , sst5TMD4 mRNA and protein levels correlated positively , and its expression was directly associated with tumor invasiveness ( cavernous / sphenoid sinus ) , and inversely correlated with age and GH / IGF1 reduction after 3 - 6 month with octreotide - LAR therapy . GNAS+ somatotropinomas expressed lower sst5TMD4 levels .", "label": "", "metadata": {}, "score": "66.274376"}
{"text": "6 , no .4 , pp .175 - 180 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . S. Gullu , H. Keles , T. Delibasi , V. Tonyukuk , N. Kamel , and G. Erdogan , \" Remission criteria for the follow - up of patients with acromegaly , \" European Journal of Endocrinology , vol .", "label": "", "metadata": {}, "score": "66.34973"}
{"text": "We describe two acromegalic patients who responded adequately to the long - acting dopamine agonist cabergoline , but surprisingly maintained normal GH and IGF - I levels once therapy was discontinued after 42 and 76 months ... .", "label": "", "metadata": {}, "score": "66.388176"}
{"text": "4 , pp .356 - 360 , 2007 .View at Google Scholar \u00b7 View at Scopus . A. Ben - Shlomo and S. Melmed , \" Clinical review 154 : the role of pharmacotherapy in perioperative management of patients with acromegaly , \" Journal of Clinical Endocrinology and Metabolism , vol . 88 , no . 3 , pp .", "label": "", "metadata": {}, "score": "66.46977"}
{"text": "Despite its inhibitory effects on steroidogenesis , the antifungal drug ketoconazole was only evaluated in series with few patients and/or short - term follow - up .", "label": "", "metadata": {}, "score": "66.600044"}
{"text": "When feasible , surgical removal of the causative tumor is the mainstay of treatment .Medical treatment can bridge the gap until surgery is performed or provide adjunctive long - term therapy to suppress hormonal excess of residual disease .", "label": "", "metadata": {}, "score": "66.87593"}
{"text": "[ 128 ] , ( ii ) a small , nonsignificant improvement ( 45 % versus 23 % , . , pretreated versus primary surgery ) [ 130 ] .", "label": "", "metadata": {}, "score": "66.905075"}
{"text": "An additional study showed a significant reduction of the diastolic blood pressure but no effect on systolic blood pressure in four hypertensive patients on antihypertensive medication during Pegvisomant therapy [ 183 ] .", "label": "", "metadata": {}, "score": "66.92796"}
{"text": "387 - 391 , 1988 .View at Google Scholar \u00b7 View at Scopus .J. G. M. Klijn , S. W. J. Lamberts , and F. H. De Jong , \" Interrelationships between tumour size , age , plasma growth hormone and incidence of extrasellar extension in acromegalic patients , \" Acta Endocrinologica , vol .", "label": "", "metadata": {}, "score": "66.97544"}
{"text": "P. G. Chiodini , R. Attanasio , R. Cozzi et al . , \" CV 205 - 502 in acromegaly , \" Acta Endocrinologica , vol .", "label": "", "metadata": {}, "score": "67.113205"}
{"text": "S3-S10 , 2009 .View at Publisher \u00b7 View at Google Scholar .I. Bernabeu , J. Cameselle - Teijeiro , F. F. Casanueva , and M. Marazuela , \" Pegvisomant - induced cholestatic hepatitis with jaundice in a patient with Gilbert 's syndrome , \" European Journal of Endocrinology , vol .", "label": "", "metadata": {}, "score": "67.11508"}
{"text": "2732 - 2740 , 2011 .View at Publisher \u00b7 View at Google Scholar .P. G. Campbell , E. Kenning , D. W. Andrews , S. Yadla , M. Rosen , and J. J. Evans , \" Outcomes after a purely endoscopic transsphenoidal resection of growth hormone - secreting pituitary adenomas , \" Neurosurgical Focus , vol .", "label": "", "metadata": {}, "score": "67.16103"}
{"text": "Cure of acromegaly as \" restitutio ad integrum \" is not possible , due to the irreversible bone changes .Thus , complete removal of the tumour , normalisation of the GH secretion and the IGF-1 concentration , as well as preservation of pituitary function , are generally aimed at .", "label": "", "metadata": {}, "score": "67.18064"}
{"text": "However , for this criterion insufficient data are available to date .Of course , stricter criteria will result in fewer complete remissions .Medical therapy is indicated in those acromegalic patients , who failed to achieve remission after surgery or in the rare patient with contraindication for surgical therapy .", "label": "", "metadata": {}, "score": "67.19391"}
{"text": "In patients with carcinoid syndrome and VIPomas , the effect of Sandostatin Injection and Sandostatin LAR Depot on tumor size , rate of growth and development of metastases has not been determined .", "label": "", "metadata": {}, "score": "67.32416"}
{"text": "Shrager JB , Wright CD , Wain JC , Torchiana DF , Grillo HC , Mathisen DJ : Bronchopulmonary carcinoid tumors associated with Cushing 's syndrome : a more aggressive variant of typical carcinoid .", "label": "", "metadata": {}, "score": "67.35363"}
{"text": "Caron P , Buscail L , Beckers A , Est\u00e8ve JP , Igout A , Hennen G , Susini C : Expression of somatostatin receptor SST4 in human placenta and absence of octreotide effect on human placental growth hormone concentration during pregnancy .", "label": "", "metadata": {}, "score": "67.479294"}
{"text": "An important improvement of surgical results in pretreated patients was reported by Colao et al .with a remission rate of 55 % ( . ) in treated versus untreated patients , respectively [ 122 ] .", "label": "", "metadata": {}, "score": "67.512146"}
{"text": "Moreover , the results for the nadir GH concentration during an OGGT and the IGF-1 concentration may be divergent or both tests may slightly fail to reach the predefined criteria .", "label": "", "metadata": {}, "score": "67.54477"}
{"text": "6 , pp .2781 - 2789 , 2010 .View at Publisher \u00b7 View at Google Scholar .M. Afargan , E. T. Janson , G. Gelerman et al . , \" Novel long - acting somatostatin analog with endocrine selectivity : potent suppression of growth hormone but not of insulin , \" Endocrinology , vol .", "label": "", "metadata": {}, "score": "67.58426"}
{"text": "L. J. Hofland , R. A. Feelders , W. W. de Herder , and S. W. J. Lamberts , \" Pituitary tumours : the sst / D2 receptors as molecular targets , \" Molecular and Cellular Endocrinology , vol .", "label": "", "metadata": {}, "score": "67.63273"}
{"text": "4 , p. E7 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. Melmed , R. Sternberg , D. Cook et al . , \" A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegaly , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "67.678474"}
{"text": "10 , pp .3419 - 3426 , 1998 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. C. Kao , E. R. Laws Jr. , and D. Zimmerman , \" Somatomedin C / insulin - like growth factor I levels after treatment of acromegaly , \" Annals of Clinical and Laboratory Science , vol .", "label": "", "metadata": {}, "score": "67.684494"}
{"text": "Firstly percentage reduction is of different significance whether calculated by the largest diameter or by volume reduction .Secondly it has been demonstrated that intra- and interindividual estimation of tumour volume by MRI may vary up to 20 % .", "label": "", "metadata": {}, "score": "67.68988"}
{"text": "Details of medical therapy with a GH - antagonist will be discussed below .Thus , while the decision for treatment with a GH receptor antagonist may still rely on the nonsuppressibility of GH during OGTT , the follow - up during therapy and dose adjustment have to be based on a methodology demonstrated to lack sufficient sensitivity for the diagnosis of remission in acromegaly .", "label": "", "metadata": {}, "score": "67.69073"}
{"text": "4 , p. E5 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .N. J. L. Gittoes , M. C. Sheppard , A. P. Johnson , and P. M. Stewart , \" Outcome of surgery for acromegaly - the experience of a dedicated pituitary surgeon , \" QJM , vol .", "label": "", "metadata": {}, "score": "67.703125"}
{"text": "Twenty - five patients ( 56.8 % ) had previous surgery and 7 ( 15.9 % ) had both surgery and radiotherapy .In only 3 of the 91 curves ( 3.3 % ) there were discordances between basal GH and IGF - I , however the latter was concordant with mean GH .", "label": "", "metadata": {}, "score": "67.74832"}
{"text": "120 - 127 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Kars , V. Delgado , E. R. Holman et al . , \" Aortic valve calcification and mild tricuspid regurgitation but no clinical heart disease after 8 years of dopamine agonist therapy for prolactinoma , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "67.75903"}
{"text": "16 - 26 , 2003 .View at Google Scholar .S. Jehle , C. M. Reyes , R. E. Sundeen , and P. U. Freda , \" Alternate - day administration of pegvisomant maintains normal serum insulin - like growth factor - I levels in patients with acromegaly , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "67.78153"}
{"text": "315 - 319 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. W. J. Lamberts , A. J. van der Lely , and L. J. Hofland , \" New somatostatin analogs : will they fulfil old promises ? \" European Journal of Endocrinology , vol .", "label": "", "metadata": {}, "score": "67.81381"}
{"text": "However , they are much cheaper than SRL or Pegvisomant and can be taken orally .At present they are mainly used as an adjunct to insufficient SRL therapy .", "label": "", "metadata": {}, "score": "67.85113"}
{"text": "He reported a mild to moderate local trauma 4 months before .A MRI showed a subgaleal cystic tumor arising in the pathway of the craniotomy .", "label": "", "metadata": {}, "score": "67.88174"}
{"text": "We found increased visceral obesity but no improvement of glucose tolerance in 5 patients after 6 months of Pegvisomant therapy resulting in normal IGF-1 concentrations .", "label": "", "metadata": {}, "score": "67.89592"}
{"text": "Thus combination therapy is also more cost efficient than monotherapy .Clinical Efficacy In addition to assessing the biochemical effects of Pegvisomant therapy a small number of trials focused on specific endpoints .", "label": "", "metadata": {}, "score": "67.93439"}
{"text": "Results The gsp oncogene was found in nine tumors ( eight somatotropinomas ) .The prevalence among somatotropinomas was 15 % and among NFPA was 7 % .", "label": "", "metadata": {}, "score": "67.9392"}
{"text": "10 , pp .3411 - 3418 , 1998 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. U. Freda , S. L. Wardlaw , and K. D. Post , \" Long - term endocrinological follow - up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly , \" Journal of Neurosurgery , vol .", "label": "", "metadata": {}, "score": "68.24604"}
{"text": "478 - 483 , 1994 .View at Google Scholar \u00b7 View at Scopus .R. S. Auriemma , M. Galdiero , M. C. De Martino et al . , \" The kidney in acromegaly : renal structure and function in patients with acromegaly during active disease and 1 year after disease remission , \" European Journal of Endocrinology , vol .", "label": "", "metadata": {}, "score": "68.3249"}
{"text": "5 , pp .293 - 299 , 1993 .View at Google Scholar \u00b7 View at Scopus .S. M. Orme , R. J. Q. Mcnally , R. A. Cartwright , and P. E. Belchetz , \" Mortality and cancer incidence in acromegaly : a retrospective cohort study , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "68.33813"}
{"text": "If SRL insufficiently suppresses GH secretion dopamine agonists can be added , preferentially Cabergoline , and this will normalise GH secretion in up to 50 % of these patients .", "label": "", "metadata": {}, "score": "68.47204"}
{"text": "Chemotherapy was initiated , followed by conventional radiotherapy .In conclusion , although pituitary adenomas respond for the vast majority of sellar tumors , concomitant symptoms such as central diabetes insipidus and rapid tumor growth should raise the suspicion of a diverse diagnosis .", "label": "", "metadata": {}, "score": "68.52551"}
{"text": "Freda et al . suggested very strict criteria for remission using a sensitive immunoradiometric assay ( GH below 0.14 \u03bc g / L during OGTT and normal IGF-1 concentration )", "label": "", "metadata": {}, "score": "68.560265"}
{"text": "About Acromegaly and Your Treatment Options .If you have been diagnosed with acromegaly , your doctor may have determined that Sandostatin \u00ae LAR Depot is the right treatment for you .", "label": "", "metadata": {}, "score": "68.682816"}
{"text": "View at Publisher \u00b7 View at Google Scholar . A. C. F. Costa , A. Rossi , E. M. Carlos , H. R. Machado , and A. C. Moreira , \" Assessment of disease activity in treated acromegalic patients using a sensitive GH assay : should we achieve strict normal GH levels for a biochemical cure ? \"", "label": "", "metadata": {}, "score": "68.692795"}
{"text": "Hence evaluation after a 3 to 6 months interval is supposed to be the most reliable [ 15 , 33 - 36 ] .The slow decline of the IGF-1 concentration is probably related to the high sensitivity of the liver after surgery , due to the now lower GH concentration .", "label": "", "metadata": {}, "score": "68.76121"}
{"text": "Indications for medical therapy are ( i ) failure to sufficiently reduce GH secretion by surgery , ( ii ) bridging the time lag until complete remission will be achieved after irradiation , ( iii ) the rare patient with contraindication to surgery .", "label": "", "metadata": {}, "score": "68.8358"}
{"text": "217 - 226 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. Rajasoorya , I. M. Holdaway , P. Wrightson , D. J. Scott , and H. K. Ibbertson , \" Determinants of clinical outcome and survival in acromegaly , \" Clinical Endocrinology , vol .", "label": "", "metadata": {}, "score": "68.84775"}
{"text": "12 , pp .741 - 745 , 1999 .View at Google Scholar \u00b7 View at Scopus .P. U. Freda , K. D. Post , J. S. Powell , and S. L. Wardlaw , \" Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "68.85105"}
{"text": "3844 - 3847 , 2010 .View at Publisher \u00b7 View at Google Scholar .S. J. Neggers , J. J. Kopchick , J. O. L. J\u00f8rgensen , and A. J. Van Der Lely , \" Hypothesis : extra - hepatic acromegaly : a new paradigm ? \" European Journal of Endocrinology , vol .", "label": "", "metadata": {}, "score": "68.87883"}
{"text": "Abosch , J. B. Tyrrell , K. R. Lamborn , L. T. Hannegan , C. B. Applebury , and C. B. Wilson , \" Transsphenoidal microsurgery for growth hormone - secreting pituitary adenomas : initial outcome and long - term results , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "68.96586"}
{"text": "4405 - 4410 , 2005 .View at Publisher \u00b7 View at Google Scholar .P. Lundin and F. Pedersen , \" Volume of pituitary macroadenomas : assessment by MRI , \" Journal of Computer Assisted Tomography , vol .", "label": "", "metadata": {}, "score": "68.9916"}
{"text": "Transsphenoidal surgery of a pituitary adenoma achieves complete remission in about 60 % of the patients .Surgical results correlate with tumour volume , especially so with supra- and parasellar adenomas , and with the preoperative GH concentration [ 1 , 3 , 10 , 37 , 52 , 104 - 107 ] .", "label": "", "metadata": {}, "score": "68.99327"}
{"text": "205 - 215 , 1993 .View at Google Scholar \u00b7 View at Scopus .J. A. Gondim , J. P. Almeida , L. A. F. de Albuquerque , E. Gomes , M. Schops , and T. Ferraz , \" Pure endoscopic transsphenoidal surgery for treatment of acromegaly : results of 67 cases treated in a pituitary center , \" Neurosurgical Focus , vol .", "label": "", "metadata": {}, "score": "69.03761"}
{"text": "590 - 593 , 2001 .View at Publisher \u00b7 View at Google Scholar .P. J. Trainer , W. M. Drake , L. Katznelson et al . , \" Treatment of acromegaly with the growth hormone - receptor antagonist pegvisomant , \" New England Journal of Medicine , vol .", "label": "", "metadata": {}, "score": "69.07572"}
{"text": "11 , pp .3808 - 3816 , 1998 .View at Google Scholar \u00b7 View at Scopus .K. Laurence , M. Cook David , and H. Hamrahian Amir , \" American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly-2011 update , \" Endocrine Practice , vol .", "label": "", "metadata": {}, "score": "69.12532"}
{"text": "OBJECTIVES :To compare the efficacy of goserelin and leuprolide on initial deceleration of growth and weight gain during the first 12 months of GnRH analogue treatment for precocious puberty .", "label": "", "metadata": {}, "score": "69.174255"}
{"text": "The efficacy of drugs especially in short - term treatment of hydatid cyst is unknown .This study was carried out to evaluate the effect of combination therapy with albendazole and ... .", "label": "", "metadata": {}, "score": "69.282425"}
{"text": "J. A. Jane Jr. , R. M. Starke , M. A. Elzoghby et al . , \" Endoscopic transsphenoidal surgery for acromegaly : remission using modern criteria , complications , and predictors of outcome , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "69.32643"}
{"text": "Aim of the present study was to assess whether brainstem transmission in acromegaly is disturbed .MATERIAL AND METHODS : The study ... .The aim of this trial was to evaluate the effects of albendazole ( ALB ) on cyst disappearance , reduction of the number of cysts and seizure recurrence .", "label": "", "metadata": {}, "score": "69.38515"}
{"text": "Preoperative SRL therapy offers no advantage in microadenomas , but may be indicated in large macroadenomas to reduce tumour volume and/or perioperative complications .Dopamine Agonists ( DAs ) .", "label": "", "metadata": {}, "score": "69.53449"}
{"text": "Among the 51 patients evaluated at diagnosis , the prevalence of discordance was 13.7 % ( 7/51 ) .Among the 58 patients evaluated after the surgical procedure , eight ( 13.8 % ) had discordant GH and IGF - I levels .", "label": "", "metadata": {}, "score": "69.55369"}
{"text": "5 , pp .1040 - 1048 , 1988 .View at Google Scholar .T. Lucas - Morante , J. Garcia - Uria , J. Estrada et al . , \" Treatment of invasive growth hormone pituitary adenomas with long - acting somatostatin analog SMS 201 - 995 before transsphenoidal surgery , \" Journal of Neurosurgery , vol .", "label": "", "metadata": {}, "score": "69.77635"}
{"text": "353 - 358 , 1998 .View at Google Scholar \u00b7 View at Scopus .Z. Arihara , K. Sakurai , S. Yamada , O. Murakami , and K. Takahashi , \" Acromegaly with normal IGF-1 levels probably due to poorly controlled diabetes mellitus , \" Tohoku Journal of Experimental Medicine , vol .", "label": "", "metadata": {}, "score": "69.8648"}
{"text": "Reduction of soft tissue swelling occurring early in the time course of medical treatment may reduce difficulties of intubation .Thus presurgical therapy may be indicated in high - risk patients and should be discussed with the anaesthetist [ 122 , 131 , 132 ] .", "label": "", "metadata": {}, "score": "69.91733"}
{"text": "663 - 670 , 2010 .View at Publisher \u00b7 View at Google Scholar .C. E. Higham , S. Rowles , D. Russell - Jones , A. M. Umpleby , and P. J. Trainer , \" Pegvisomant improves insulin sensitivity and reduces overnight free fatty acid concentrations in patients with acromegaly , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "70.05299"}
{"text": "Combination Therapy of SRL and Dopamine Agonists In patients insufficiently responding to SRL or dopamine agonist treatment , combination therapy may be an option to further decrease GH secretion [ 151 , 157 - 163 ] .", "label": "", "metadata": {}, "score": "70.069595"}
{"text": "The extent of neovascularisation , as well as the expression of VEGF , correlates positively with the degree of invasiveness in some pituitary adenomas [ 69 ] .", "label": "", "metadata": {}, "score": "70.10666"}
{"text": "R. R. Grunstein , K. Y. Ho , and C. E. Sullivan , \" Sleep apnea in acromegaly , \" Annals of Internal Medicine , vol .", "label": "", "metadata": {}, "score": "70.245346"}
{"text": "Yet most of the specific mechanisms inducing receptor dimerisation , as well as the molecular consequences of this process , are still not clear .Further investigations are necessary to predict the effects of these many interactions on the decline of the GH concentration and inhibition of tumour growth .", "label": "", "metadata": {}, "score": "70.25619"}
{"text": "Pre existing psychiatric illness is a relative contraindication to DA therapy .High dose Cabergoline therapy has been reported to cause cardiac valvular abnormalities .With long - term , high dose Cabergoline therapy echocardiographic follow - up has been recommended [ 61 , 164 , 165 ] .", "label": "", "metadata": {}, "score": "70.29782"}
{"text": "Primary medical therapy may achieve tumour stabilisation in most patients .Efficacy of primary medical therapy may be comparable to postoperative medical therapy .With long - term therapy a dose reduction may be possible .", "label": "", "metadata": {}, "score": "70.30454"}
{"text": "MA created the figures and reviewed the anthropometric data .GK performed the somatostatin sub- typing in the pathological material .AY was the attending physician while the patient was hospitalized twice during the course of her disease .", "label": "", "metadata": {}, "score": "70.30845"}
{"text": "The increasing number of reported cases may help to better understand its peculiarities such as the existence of a clear clinical radiological dissociation and to unveil pathophysiological aspects .", "label": "", "metadata": {}, "score": "70.318"}
{"text": "With long - term therapy the SRL dose can be reduced in most patients .The determination of the GH and IGF-1 concentration should be performed immediately before the next injection , that is , at the nadir of the drug 's plasma concentration .", "label": "", "metadata": {}, "score": "70.42009"}
{"text": "95 - 99 , 1992 .View at Google Scholar \u00b7 View at Scopus . D. Milani , J. D. Carmichael , J. Welkowitz et al . , \" Variability and reliability of single serum IGF - I measurements : impact on determining predictability of risk ratios in disease development , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "70.43101"}
{"text": "251 - 258 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .I. E. Bonapart , R. van Domburg , S. M. T. H. ten Have et al . , \" The \" bio - assay \" quality of life might be a better marker of disease activity in acromegalic patients than serum total IGF - I concentrations , \" European Journal of Endocrinology , vol .", "label": "", "metadata": {}, "score": "70.446"}
{"text": "53 - 60 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. Brabant , \" Insulin - like growth factor - I : marker for diagnosis of acromegaly and monitoring the efficacy of treatment , \" European Journal of Endocrinology , Supplement , vol .", "label": "", "metadata": {}, "score": "70.550446"}
{"text": "Jimenez et al . showed in a small heterogeneous group of seven acromegalic patients , treated with 20 mg Pegvisomant for at least 18 months , a small but significant increase in bone mineral density [ 188 , 189 ] .", "label": "", "metadata": {}, "score": "70.618744"}
{"text": "The determination of the IGF-1 concentration is used for follow - up during therapy and dose adjustment .Problems of the IGF-1 assay have already been discussed .", "label": "", "metadata": {}, "score": "70.66759"}
{"text": "However because of the high price of all SRL , dopamine agonists should be the initial therapeutic principle in patients with low basal GH / IGF-1 concentrations .", "label": "", "metadata": {}, "score": "70.69467"}
{"text": "One year later no recurrences have been detected .The case reported has two particular features : the local trauma as a potential trigger for tumor progression and the rapidly growing pattern of the ectopic recurrent tumor .", "label": "", "metadata": {}, "score": "70.734215"}
{"text": "Sandostatin \u00ae LAR Depot ( octreotide acetate for injectable suspension ) is indicated for patients in whom initial treatment with immediate release Sandostatin \u00ae ( octreotide acetate ) Injection has been shown to be effective and tolerated for : .", "label": "", "metadata": {}, "score": "70.771355"}
{"text": "12 , pp .1845 - 1852 , 1991 .View at Google Scholar \u00b7 View at Scopus .J. J. Kopchick , \" Discovery and development of a new class of drugs : GH antagonists , \" Journal of Endocrinological Investigation , vol .", "label": "", "metadata": {}, "score": "70.7817"}
{"text": "[ Time Frame : 7 months ] [ Designated as safety issue : No ] .Change in mean urinary free cortisol from baseline at every month in the core and every 3 months in extension within the two Pasireotide LAR regimens [ Time Frame : 26 months ] [ Designated as safety issue : Yes ] .", "label": "", "metadata": {}, "score": "70.80018"}
{"text": "3537 - 3542 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .N. R. Biermasz , F. W. Dekker , A. M. Pereira et al . , \" Determinants of survival in treated acromegaly in a single center : predictive value of serial insulin - like growth factor I measurements , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "70.80591"}
{"text": "Hormonal evaluation was made with an oral glucose tolerance test ( OGTT ) with the IGF - I being assessed in the basal sample at diagnosis and after 3 months of the adenomectomy .", "label": "", "metadata": {}, "score": "70.842865"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. L. Espinosa - de - los - Monteros , M. Mercado , E. Sosa et al . , \" Changing patterns of insulin - like growth factor - I and glucose - suppressed growth hormone levels after pituitary surgery in patients with acromegaly , \" Journal of Neurosurgery , vol .", "label": "", "metadata": {}, "score": "70.902405"}
{"text": "5 , pp .557 - 558 , 1995 .View at Google Scholar \u00b7 View at Scopus .G. Lombardi , A. Colao , D. Ferone et al . , \" CV 205 - 502 treatment in therapy - resistant acromegalic patients , \" European Journal of Endocrinology , vol .", "label": "", "metadata": {}, "score": "70.91904"}
{"text": "Probably due to the longer washout phase of depot preparations no such complications have been reported with the slow release formulations .SRL reduce gastrin secretion .", "label": "", "metadata": {}, "score": "71.01242"}
{"text": "Retrospective chart review of all patients who underwent GH from 1991 to 2001 .Demographics , obstetric history , delivery ... .The prevalence of discordance in acromegalics has been described to ... .", "label": "", "metadata": {}, "score": "71.02945"}
{"text": "4 , pp .465 - 471 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. S. Bates , W. Van't Hoff , J. M. Jones , and R. N. Clayton , \" An audit of outcome of treatment in acromegaly , \" Quarterly Journal of Medicine , vol .", "label": "", "metadata": {}, "score": "71.21387"}
{"text": "W. Y. Chen , D. C. Wight , B. V. Mehta , T. E. Wagner , and J. J. Kopchick , \" Glycine 119 of bovine growth hormone is critical for growth - promoting activity , \" Molecular Endocrinology , vol .", "label": "", "metadata": {}, "score": "71.29463"}
{"text": "However , it has been demonstrated that this exchange does not affect affinity but removes two sites for polyethylene glycol ( PEG ) binding , which are within the native binding site [ 166 , 167 ] .", "label": "", "metadata": {}, "score": "71.36195"}
{"text": "4099 - 4103 , 2000 .View at Publisher \u00b7 View at Google Scholar .M. Kurosaki , D. K. L\u00fcdecke , J. Flitsch , and W. Saeger , \" Surgical treatment of clinically nonsecreting pituitary adenomas in elderly patients , \" Neurosurgery , vol .", "label": "", "metadata": {}, "score": "71.406235"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : The purpose of the present study is to evaluate the prevalence of the gsp oncogene in Brazilian patients harboring somatotropinomas and non - functioning pituitary adenomas ( NFPA ) .", "label": "", "metadata": {}, "score": "71.46149"}
{"text": "This has been confirmed in five acromegalic patients on Pegvisomant .We demonstrated a significant increase of intra - abdominal fat by electron beam computer tomography , while the amount of subcutaneous abdominal fat remained unchanged [ 174 ] .", "label": "", "metadata": {}, "score": "71.52243"}
{"text": "The various available assays for the determination of GH use different antibodies with distinct affinity to the GH molecule .These antibodies may recognise not only separate epitopes but even different GH isoforms .", "label": "", "metadata": {}, "score": "71.5942"}
{"text": "Information on their mechanism of action , and some pharmakokinetic data are included .Special emphasis is given to the difficulties to define remission criteria of acromegaly due to technical assay problems .", "label": "", "metadata": {}, "score": "71.62301"}
{"text": "11 - 16 , 2011 .View at Publisher \u00b7 View at Google Scholar . U.Pl\u00f6ckinger and T. Reuter , \" Pegvisomant increases intra - abdominal fat in patients with acromegaly : a pilot study , \" European Journal of Endocrinology , vol .", "label": "", "metadata": {}, "score": "71.65087"}
{"text": "Published by Elsevier Ireland Ltd. .[ Show abstract ] [ Hide abstract ] ABSTRACT : The purpose of the present clinical case is to remind clinicians that craniopharyngiomas , which are benign neoplasms with a high incidence of local recurrences , may also present ectopic recurrences which may at first go unsuspected .", "label": "", "metadata": {}, "score": "71.71896"}
{"text": "demonstrating a decreased growth fraction and an increased proportion of cells in G1 and M - phases .Thus the antiproliferative effects of SRL are probably related to an inhibition of cell growth , that is , reduced cell cycling rather than an increase in apoptosis [ 113 , 114 ] .", "label": "", "metadata": {}, "score": "71.83836"}
{"text": "Antibody development against Pegvisomant has been observed , their clinical relevance is unknown .Overall Conclusions .Therapeutic interventions should be orientated on those biochemical indices that indicate a safe GH / IGF-1 concentration , as data on complete remission or even cure of acromegaly are still highly controversial due to problems of assay technologies and standardisation .", "label": "", "metadata": {}, "score": "72.01001"}
{"text": "This may be due the exon-3 polymorphism of the human GH - receptor gene .40%-50 % of the Western population carries an exon-3 deleted GH - receptor .", "label": "", "metadata": {}, "score": "72.03005"}
{"text": "He was submitted to neurosurgery and histological examination revealed an adamantinomatous craniopharyngioma .Postoperative magnetic resonance imaging ( MRI ) showed complete tumor resection .The patient remained asymptomatic with no imaging signs of local recurrence during follow up .", "label": "", "metadata": {}, "score": "72.08011"}
{"text": "Serum IGF-1 had normalised in 75 % of the patients , but there was no correlation to the observed metabolic changes [ 183 ] .Bone Formation Patients with acromegaly tend to have normal or even slightly increased bone mineral density .", "label": "", "metadata": {}, "score": "72.09305"}
{"text": "The aim of this study was to evaluate the effectiveness of short - term ( 3 months ) and long - term ( 12 - 24 months ) treatment with cabergoline in patients with CD .", "label": "", "metadata": {}, "score": "72.289314"}
{"text": "The IGF-1 concentration may be elevated , despite an already normal GH suppression during OGTT , leading to divergent results .This can be observed in up to 30 % of postoperative patients [ 16 , 19 ] .", "label": "", "metadata": {}, "score": "72.34013"}
{"text": "Farwell AP , Devlin JT , Stewart JA : Total suppression of cortisol excretion by ketoconazole in the therapy of the ectopic adrenocorticotropic hormone syndrome .", "label": "", "metadata": {}, "score": "72.35939"}
{"text": "Unfortunately the spectrum of isoforms recognised is rarely indicated .Furthermore the reference preparation used for the assay may differ between assays .Thus GH determination with different assays leads to divergent results .", "label": "", "metadata": {}, "score": "72.42473"}
{"text": "The brachial artery vascular function , which is known to be decreased in active acromegaly , improved in 10 patients treated with 10 - 40 mg / d Pegvisomant for 18 months [ 186 ] .", "label": "", "metadata": {}, "score": "72.46536"}
{"text": "Herman - Bonert V , Seliverstov M , Melmed S : Pregnancy in acromegaly : successful therapeutic outcome .J Clin Endocrinol Metab 1998 , 83:727 - 731 .", "label": "", "metadata": {}, "score": "72.54602"}
{"text": "PATIENTS AND METHODS : A cohort of 402 patients ( 269 males , 133 ... .OBJECTIVE :To further assess the safety and long - term efficacy of endoscopic resection of colloid cysts of the third ventricle .", "label": "", "metadata": {}, "score": "72.699356"}
{"text": "OBJECTIVE :To investigate puberty in a group of thalassemic patients with delayed or arrested pubertal development and to compare the effects of hormonal and L - carnitine therapy on puberty in those patients .", "label": "", "metadata": {}, "score": "72.7797"}
{"text": "twice daily for 28 days each ) for the effect on GH , tumour growth , and glucose metabolism .The GH concentration was reduced to below 2.5 \u03bc g / L in 9 % and 19 % of the patients for Octreotide and Pasireotide , respectively .", "label": "", "metadata": {}, "score": "72.82929"}
{"text": "injections were positively correlated to tumour shrinkage [ 78 ] , while no such correlation was reported with the slow release preparations [ 118 , 119 ] .", "label": "", "metadata": {}, "score": "72.84784"}
{"text": "METHODS : We reviewed PubMed publications since the first use ... .OBJECTIVES : Acromegaly is associated by various systemic complications , involving also the nervous system .", "label": "", "metadata": {}, "score": "72.88946"}
{"text": "This may explain the slow growth velocity of most pituitary adenomas .Interestingly in somatotropinomas microvessel density was negatively correlated with the patients ' age , possibly explaining the clinical observation of more aggressive somatotroph adenomas in young compared to older adults [ 71 - 73 ] .", "label": "", "metadata": {}, "score": "72.98711"}
{"text": "11 , pp .924 - 933 , 2009 .View at Publisher \u00b7 View at Google Scholar . A. Luger , U. Feldt - Rasmussen , R. Abs et al . , \" Lessons learned from 15 years of KIMS and 5 years of ACROSTUDY , \" Hormone Research in Paediatrics , vol .", "label": "", "metadata": {}, "score": "72.98912"}
{"text": "Intraindividual variability ranged from 3 % to 36 % [ 55 ] .( iv )Recently it was demonstrated , that even two high quality assays , using the same international standard , were not comparable [ 42 ] .", "label": "", "metadata": {}, "score": "73.11036"}
{"text": "View at Publisher \u00b7 View at Google Scholar .S. R. George , K. Kovacs , and S. L. Asa , \" Effect of SMS 201 - 995 , a long - acting somatostatin analogue , on the secretion and morphology of a pituitary growth hormone cell adenoma , \" Clinical Endocrinology , vol .", "label": "", "metadata": {}, "score": "73.11392"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. E. Turner , Z. Nagy , K. C. Gatter , M. M. Esiri , A. L. Harris , and J. A. H. Wass , \" Angiogenesis in pituitary adenomas - relationship to endocrine function , treatment and outcome , \" Journal of Endocrinology , vol .", "label": "", "metadata": {}, "score": "73.17615"}
{"text": "Exons 8 and 9 ( including codons 201 and 227 , respectively ) of the GNAS gene were amplified by polymerase chain reaction ( PCR ) .", "label": "", "metadata": {}, "score": "73.345215"}
{"text": "or a median dose of Pegvisomant of 130 mg / week [ 176 , 177 ] .The dose of Pegvisomant needed for normalisation of the IGF-1 concentration is positively correlated to the basal age- and sex - adjusted IGF-1 concentration and is independent of pretreatment modalities ( primary medical therapy versus postoperative therapy or combination therapy ) [ 178 ] .", "label": "", "metadata": {}, "score": "73.41336"}
{"text": "As disease mostly develops at younger age and penetrance is low , the timing and duration of follow up of carriers without overt disease requires further study .", "label": "", "metadata": {}, "score": "73.43203"}
{"text": "Earlier investigation , that is , an oral glucose load one week after surgery , has been claimed to be as reliable [ 8 , 33 ] .", "label": "", "metadata": {}, "score": "73.542984"}
{"text": "Postoperative normalisation of IGF-1 can take some time [ 53 ] ( see above ) .False low values may be due to surgical stress or fasting , as both physiologically reduce the IGF-1 concentration .", "label": "", "metadata": {}, "score": "73.59205"}
{"text": "During primary therapy , remission criteria for GH or IGF-1 were achieved by both SRL in 50 % or 60 % , respectively [ 80 ] .", "label": "", "metadata": {}, "score": "73.63793"}
{"text": "The possible pitfalls of the IGF-1 determination are either due to technical issues related to the assay system or to the reference preparation .In addition physiological variations of the IGF-1 concentration have to be taken into account .", "label": "", "metadata": {}, "score": "73.68369"}
{"text": "As there was a rapid tumor growth and the patient had concomitant central diabetes insipidus and elevated testosterone levels , a GCT was suspected and confirmed by elevated serum concentration of \u03b2 - human chorionic gonadotrophin .", "label": "", "metadata": {}, "score": "73.779236"}
{"text": "Laboratory results revealed pronounced nonketotic hyperglycemia [ 27 mmol / L ( 486 mg / dL ) ; HbA1c 140 mmol / mol ( 15 % ) ] and brain MRI showed bilateral T1 hyperintensity in the basal ganglia , more noticeable on the right side .", "label": "", "metadata": {}, "score": "73.89137"}
{"text": "C. Berg , T. E. Wessendorf , F. Mortsch et al . , \" Influence of disease control with pegvisomant on sleep apnoea and tongue volume in patients with active acromegaly , \" European Journal of Endocrinology , vol .", "label": "", "metadata": {}, "score": "74.02162"}
{"text": "Patients with carcinoid tumors and VIPomas should adhere closely to their scheduled return visits for reinjection in order to minimize exacerbation of symptoms .Patients with acromegaly should adhere to their return visit schedule to help assure steady control of GH and IGF-1 levels .", "label": "", "metadata": {}, "score": "74.108215"}
{"text": "Growth - Hormone Receptor - Antagonist .Following incomplete surgery established medical therapies with SRL , dopamine agonists or a combination of both successfully reduce GH secretion in up to 75 - 80 % of the patients .", "label": "", "metadata": {}, "score": "74.27599"}
{"text": "RESULTS :The mean patient age was 32.4 ... .Consensus statement of the Polish Society for Endocrinology , regarding presurgical somatostatin analogs in acromegaly has been presented .", "label": "", "metadata": {}, "score": "74.326515"}
{"text": "276 , no .17 , pp .14027 - 14036 , 2001 .View at Google Scholar \u00b7 View at Scopus . H. E. Turner , Z. Nagy , K. C. Gatter , M. M. Esiri , A. L. Harris , and J. A. H. Wass , \" Angiogenesis in pituitary adenomas and the normal pituitary gland , \" Journal of Clinical Endocrinology and Metabolism , vol . 85 , no . 3 , pp .", "label": "", "metadata": {}, "score": "74.370415"}
{"text": "Importantly tumour growth during SRL therapy is very rare ( Table 3 ) .However , there are some caveats : ( i ) none of these studies was randomized , ( ii ) in experienced hands the surgical risk is low , even in very old patients [ 137 ] , and finally ( iii ) lifelong SRL treatment is very expensive .", "label": "", "metadata": {}, "score": "74.39177"}
{"text": "In contrast Freda and coworkers found a persistently normal IGF-1 concentration in only 3 of 14 ( 21 % ) patients , without a preferential effect in patients with hyperprolactinemia [ 149 ] .", "label": "", "metadata": {}, "score": "74.42314"}
{"text": "BACKGROUND : Expert surgery in acromegaly is curative in about only 60 % of cases .Postsurgical radiation therapy is associated with a high incidence of hypopituitarism and its effect on growth hormone decrease is slow .", "label": "", "metadata": {}, "score": "74.558525"}
{"text": "METHODS : Sixteen patients ( aged 2 months-22 years ) underwent percutaneous treatment for LM of the trunk and extremities from 2002 to 2007 .The LM involved the ...", "label": "", "metadata": {}, "score": "74.663086"}
{"text": "95 - 102 , 1994 .View at Google Scholar \u00b7 View at Scopus .B. Swearingen , F. G. Barker , L. Katznelson et al . , \" Long - term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "74.66972"}
{"text": "Tumour volume reduction is generally less in tumour remnants or after irradiation .In those patients tumour shrinkage has been reported in 27 % , while shrinkage occurred in up to 52 % in therapy - na\u00efve patients [ 117 ] .", "label": "", "metadata": {}, "score": "74.70132"}
{"text": "This regimen resulted in fluctuating drug concentrations , with an increase in GH usually observable six hours after the injection [ 76 ] .Comparable results were published by Ezzat et al . in a similar population of 152 acromegalic patients treated with two different dose regimens ( 300 \u03bc g / d or 750 \u03bc g / d ) .", "label": "", "metadata": {}, "score": "74.774445"}
{"text": "5 , pp .2271- 2274 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. R. Clemmons , \" Consensus statement on the standardization and evaluation of growth hormone and insulin - like growth factor assays , \" Clinical Chemistry , vol .", "label": "", "metadata": {}, "score": "74.86561"}
{"text": "This again highlights the difficulties in deciding on medical therapy based on the postoperative biochemical indicators in acromegaly [ 50 ] .Insulin - Like Growth Factor-1 .", "label": "", "metadata": {}, "score": "74.90579"}
{"text": "Related links .Share .Arquivos Brasileiros de Endocrinologia & Metabologia .On - line version ISSN 1677 - 9487 .Abstract .VIEIRA NETO , Leonardo ; TABOADA , Giselle Fernandes and GADELHA , M\u00f4nica Roberto .", "label": "", "metadata": {}, "score": "74.98614"}
{"text": "Both regimens achieved comparable results concerning the percentage of patients in remission as well as the mean GH ( mean of a 5-point GH profile ) or the IGF-1 concentration .", "label": "", "metadata": {}, "score": "75.00845"}
{"text": "This may be due to ( i ) an SRL - induced direct suppression of the IGF-1 generation of the hepatocyte or ( ii ) a disturbance of the physiologic response of GH to oral glucose induced by SRL .", "label": "", "metadata": {}, "score": "75.05597"}
{"text": "No tachyphylaxia has been observed during long - term therapy .This is in contrast to the declining efficacy in neuroendocrine gastrointestinal tumours treated with SRL .", "label": "", "metadata": {}, "score": "75.222626"}
{"text": "A 20 % lower dose per kg bodyweight achieved normalisation of the IGF-1 concentration compared to patients with the full - length receptor variant [ 181 ] .", "label": "", "metadata": {}, "score": "75.24193"}
{"text": "PURPOSE : We compared the efficacy and safety of multiple session 99 % ethanol sclerotherapy to single session OK-432 sclerotherapy for the treatment of simple renal cysts .", "label": "", "metadata": {}, "score": "75.27365"}
{"text": "However , in a recent consensus discussion , this criterion failed to be seen as reliable and sufficiently evidenced based .The GH concentration determined by new and more sensitive assays is generally lower compared to the earlier used polyclonal assays .", "label": "", "metadata": {}, "score": "75.302765"}
{"text": "Retrospective cohort analysis .PATIENTS : Forty children with precocious puberty treated with either goserelin or leuprolide ( 33 females , mean age 7.3 ... .", "label": "", "metadata": {}, "score": "75.39814"}
{"text": "Our purpose was to evaluate the efficacy and safety of EMR ... .Dekkers O M OM Department of Endocrinology and Metabolic Diseases C4-R , Leiden University Medical Center , P.O. Box 9600 , 2300 RC Leiden , The Netherlands .", "label": "", "metadata": {}, "score": "75.40285"}
{"text": "Cabergoline is most often used .DA monotherapy results in complete remission in less than one third of the patients .Patients with insufficient GH / IGF-1 suppression during SRL monotherapy may benefit from addition of a dopamine agonist , which will further lower GH / IGF-1 concentration in up to 50 % .", "label": "", "metadata": {}, "score": "75.43181"}
{"text": "1588 - 1593 , 2005 .View at Publisher \u00b7 View at Google Scholar .C. Muto , K. Chiba , and T. Suwa , \" Population pharmacokinetic and pharmacodynamic modeling of pegvisomant in Asian and Western acromegaly patients , \" Journal of Clinical Pharmacology , vol .", "label": "", "metadata": {}, "score": "75.52121"}
{"text": "To reduce this interference several methods with varying efficacy are used .The \" gold standard \" is the addition of IGF-2 .IGF-2 has a higher binding affinity for IGF - binding proteins than IGF-1 .", "label": "", "metadata": {}, "score": "75.58128"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Bidlingmaier and P. U. Freda , \" Measurement of human growth hormone by immunoassays : current status , unsolved problems and clinical consequences , \" Growth Hormone and IGF Research , vol .", "label": "", "metadata": {}, "score": "75.731125"}
{"text": "Tumour shrinkage occurred in 13 of 21 patients , with a mass reduction by more than half in 5 GH-/PRL co - secreting adenomas [ 148 ] .", "label": "", "metadata": {}, "score": "75.76976"}
{"text": "475 - 481 , 2000 .View at Google Scholar \u00b7 View at Scopus . A. E. M. Smals , G. F. F. M. Pieters , A. G. H. Smals , and P. W. C. Kloppenborg , \" Sex difference in the relation between sellar volume and basal and GH - releasing hormone stimulated GH in acromegaly , \" Acta Endocrinologica , vol .", "label": "", "metadata": {}, "score": "75.90598"}
{"text": "The mean tumour volume reduction was 19.4 % for the whole cohort , irrespective of whether individually significant shrinkage occurred [ 108 ] .This paper included definitions of tumour shrinkage over a wide range of volume reduction ( from shrinkage of more than 2 mm , or 10 % to 45 % ) .", "label": "", "metadata": {}, "score": "75.95313"}
{"text": "Pegvisomant therapy resulted in a reduction of the tongue volume and this was accompanied by a decrease of the apnoea - hypopnoea index in patients with sleep - apnoea .", "label": "", "metadata": {}, "score": "76.12188"}
{"text": "No preview \u00b7 Article \u00b7 Mar 2009 \u00b7 The Journal of Clinical Endocrinology and Metabolism .[ Show abstract ] [ Hide abstract ] ABSTRACT : Germ cell tumors ( GCT ) are a heterogeneous group of lesions whose origin is not well established .", "label": "", "metadata": {}, "score": "76.19261"}
{"text": "12 , pp .1628 - 1643 , 2011 .View at Publisher \u00b7 View at Google Scholar .J. D. Veldhuis , M. Bidlingmaier , J. Bailey , D. Erickson , and P. Sandroni , \" A pegylated growth hormone receptor antagonist , pegvisomant , does not enter the brain in humans , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "76.28085"}
{"text": "Quinagolide Quinagolide is a nonergot selective D2 agonist .Half - life during steady state is about 17 hours .There are relatively few data on the effect of Quinagolide in acromegaly [ 152 - 156 ] .", "label": "", "metadata": {}, "score": "76.30327"}
{"text": "A complete or partial clinical response to SSA therapy is generally achieved in at least 50 % of the patients with neuroendocrine syndrome .Many studies reported a clinical response in 70 - 90 % of functioning NETs .", "label": "", "metadata": {}, "score": "76.38711"}
{"text": "Analysis of ... .GH may improve phosphate balance and height in X - linked hypophosphatemic rickets ( XLH ) .This study evaluated the impact of exclusive rhGH therapy on phosphate homeostasis and growth .", "label": "", "metadata": {}, "score": "76.39143"}
{"text": "Yet the clinical relevance is not clear .During an OGTT the first phase of insulin - secretion is reduced and the subsequent insulin increase is delayed .", "label": "", "metadata": {}, "score": "76.461"}
{"text": "METHOD : Thirty seven patients ( 21 females , 16 ... .OBJECTIVE :To evaluate the efficacy and safety of recombinant human growth hormone ( rhGH ) in the treatment of patients with chronic liver failure .", "label": "", "metadata": {}, "score": "76.88878"}
{"text": "( i ) Poor assay standardisation is one of the basic problems .The only available standard preparation ( 87/518 ) is impure , containing only 40 % of IGF-1 .", "label": "", "metadata": {}, "score": "76.95395"}
{"text": "BACKGROUND : Gastric carcinoid tumours type 1 ( GCA1 ) originate from hyperplastic enterochromaffin - like ( ECL ) cells secondary to hypergastrinaemia .Treatment with somatostatin analogues ( SSA ) might impede ECL - cell hyperplasia by suppressing gastrin secretion and/or by a direct anti - proliferative effect on ECL cells .", "label": "", "metadata": {}, "score": "77.2789"}
{"text": "Excellent relationships between the family , endocrinologists and geneticists are essential and ideally these families should be managed in centers with specialist expertise .No preview \u00b7 Article \u00b7 Jan 2013 \u00b7 The Journal of Clinical Endocrinology and Metabolism .", "label": "", "metadata": {}, "score": "77.57471"}
{"text": "Excellent effects are reported concerning headache , hyperhidrosis , soft tissue swelling , arthritic pain , and carpal - tunnel syndrome .Side Effects Subcutaneous Octreotide injections can result in reddening of the skin and burning sensations at the injection site .", "label": "", "metadata": {}, "score": "77.603035"}
{"text": "Functioning metastasis of differentiated carcinoma of the thyroid should be considered in patients with hyperthyroidism and low thyroid radioiodine uptake .[ Show abstract ] [ Hide abstract ] ABSTRACT : Insulin signalling pathways were investigated in a 33 year - old woman with immunologic insulin resistance .", "label": "", "metadata": {}, "score": "78.05281"}
{"text": "Conventional treatment was discontinued 1 month prior GH ... .Most pituitary surgery centres prescribe perioperative glucocorticoids to subjects undergoing transsphenoidal pituitary adenomectomy ( TSA ) , despite reports suggesting this may be unnecessary .", "label": "", "metadata": {}, "score": "78.178566"}
{"text": "Combination therapy rather than Pegvisomant monotherapy is preferred due to its higher cost - effectiveness .With these therapeutic strategies up to 95 % of the patients will achieve complete remission ( Figure 1 ) .", "label": "", "metadata": {}, "score": "78.2912"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .N. Hattori , A. Shimatsu , Y. Kato et al . , \" Growth hormone responses to oral glucose loading measured by highly sensitive enzyme immunoassay in normal subjects and patients with glucose intolerance and acromegaly , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "78.42944"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : The GH / IGF1 response of somatotropinomas to somatostatin analogues ( SSA ) is associated to their pattern of somatostatin receptor ( sst1-sst5 ) expression .", "label": "", "metadata": {}, "score": "78.59297"}
{"text": "We report the case of a young adult male patient with a mixed GCT that presented with a sellar tumor with suprasellar extension .The patient seeked medical attention because of seizures and magnetic resonance imaging evidenced a tumor of the sellar region .", "label": "", "metadata": {}, "score": "78.62884"}
{"text": "Forty - two patients had multiple pituitary hormone deficiencies and 27 had isolated GHD .OBJECTIVE :To analyse and discuss the diagnosis and treatment of pituitary microadenoma .", "label": "", "metadata": {}, "score": "78.70316"}
{"text": "No differences were found in age , sex , GH , and IGF - I levels or tumor volume at diagnosis between gsp+ and gsp- patients .", "label": "", "metadata": {}, "score": "78.73358"}
{"text": "Pathological examination confirmed an ACTH - positive carcinoid tumor .Case 2 : 53-year - old woman presented with very rapid onset ECS .", "label": "", "metadata": {}, "score": "78.87649"}
{"text": "711 - 718 , 1992 .View at Google Scholar \u00b7 View at Scopus .I. Lancranjan and A. B. Atkinson , \" Results of a European multicentre study with Sandostatin LAR in acromegalic patients , \" Pituitary , vol .", "label": "", "metadata": {}, "score": "78.937164"}
{"text": "217 - 224 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .L. J. Woodhouse , A. Mukherjee , S. M. Shalet , and S. Ezzat , \" The influence of growth hormone status on physical impairments , functional limitations , and health - related quality of life in adults , \" Endocrine Reviews , vol .", "label": "", "metadata": {}, "score": "78.96996"}
{"text": "A careful histopathological examination of the surgically excised pituitary tissue has a key role to arouse the suspicion and guide the investigation of a secondary cause of acromegaly .", "label": "", "metadata": {}, "score": "78.982635"}
{"text": "In patients with radiotherapy the relation of GH to IGF-1 is disturbed and can not be relied upon [ 41 ] .A divergence between the concentration of IGF-1 and the GH nadir during OGTT has been observed in both directions , that is , an increased IGF-1 and a normal GH nadir or a normal IGF-1 and insufficient suppression of the GH concentration [ 15 , 42 - 44 ] .", "label": "", "metadata": {}, "score": "79.01534"}
{"text": "27 - 35 , 2009 .View at Publisher \u00b7 View at Google Scholar . A. Soto Moreno , R. Guerrero V\u00e1zquez , E. Venegas Moreno , S. Palma Milla , J. P. Casta\u00f1o , and A. Leal Cerro , \" Self - limited acute hepatotoxicity caused by pegvisomant , \" Pituitary , vol .", "label": "", "metadata": {}, "score": "79.08255"}
{"text": "An abdominal ultrasound performed before initiation of medical treatment showed a solid / cystic lesion superiorly to the right kidney .An abdominal MRI confirmed an adrenal tumor .", "label": "", "metadata": {}, "score": "79.15181"}
{"text": "Mechanism of Action Pegvisomant , the only available GHA , is an analogue of the 22 kD GH molecule .Modification of the GH molecule , exchanging the amino acid glycin at position 120 in the third helix , results in a GH antagonistic effect .", "label": "", "metadata": {}, "score": "79.16946"}
{"text": "It has been shown that sst interact with each other or with other G - protein coupled receptors forming homo- or heterodimers , further increasing the complexity of somatostatin receptor activation .", "label": "", "metadata": {}, "score": "79.22385"}
{"text": "A healthy full - term baby was born ( Table 2 ) .Two and three years later , respectively , our patient delivered two more healthy full - term babies ( Table 2 ) .", "label": "", "metadata": {}, "score": "79.33576"}
{"text": "CONTEXT :Although transsphenoidal surgery remains the first - line treatment in Cushing 's disease ( CD ) , recurrence is observed in about 20 % of cases .", "label": "", "metadata": {}, "score": "79.3638"}
{"text": "Practical Issues The duration of treatment necessary to induce significant tumour shrinkage is variable .In most responding patients tumour shrinkage can be observed within 3 - 6 months , while some may need SRL therapy up to one year to achieve significant volume reduction .", "label": "", "metadata": {}, "score": "79.47761"}
{"text": "Only one case report described low intra - uterine growth ( 5th to 10th percentile ) with no other unusual morphological fea- tures [ 12].", "label": "", "metadata": {}, "score": "79.510124"}
{"text": "Recruiting Status : We are opening enrollment for this trial in August , 2014 .Glucocorticoid Receptor Blockade with Mifepristone in Patients with Mild Adrenal Hypercortisolism .", "label": "", "metadata": {}, "score": "79.52154"}
{"text": "Ten children and adolescents ( mean age , 12.6 + /- 4.5 years ; 6 males ) with CD and poor height growth were treated with open - label recombinant GH , 0.043 mg / kg / day administered via subcutaneous injection , ... .", "label": "", "metadata": {}, "score": "79.63376"}
{"text": "DR2 is the predominant DR subtype in NPs , NFPAs , and somatotropinomas .The fact that DR1 , DR4 , and DR5 are also expressed in many adenomas tested suggests that these receptors might also play a role in the therapeutic impact of postsurgical medical therapies in patients with NFPA and acromegaly .", "label": "", "metadata": {}, "score": "79.74971"}
{"text": "METHODS : Eighty - eight subjects took part in ... .Background : Subjects with non - functioning pituitary adenomas ( NFAs ) frequently develop growth hormone deficiency due to tumour expansion or as a consequence of tumour therapy .", "label": "", "metadata": {}, "score": "79.88051"}
{"text": "Untreated acromegalic patients have a decreased fat mass due to the lipolytic effect of GH .Increased lipolysis causes insulin resistance and deterioration of glucose tolerance .", "label": "", "metadata": {}, "score": "79.88624"}
{"text": "Case 1 : 31-year - old man was diagnosed with ectopic ACTH - dependent Cushing 's syndrome ( ECS ) .Thorax CT revealed a 1.3 cm nodular opacity in upper left lobe , suggestive of residual lesion .", "label": "", "metadata": {}, "score": "79.99524"}
{"text": "374 - 378 , 1998 .View at Publisher \u00b7 View at Google Scholar .P. U. Freda , C. M. Reyes , A. T. Nuruzzaman , R. E. Sundeen , A. G. Khandji , and K. D. Post , \" Cabergoline therapy of growth hormone & growth hormone / prolactin secreting pituitary tumors , \" Pituitary , vol .", "label": "", "metadata": {}, "score": "80.05878"}
{"text": "A 23-year - old man presented with signs and symptoms of acromegaly .Laboratory evaluation confirmed the diagnosis and magnetic resonance imaging ( MRI ) revealed a sellar mass which was thought to be a macroadenoma and surgically resected .", "label": "", "metadata": {}, "score": "80.12372"}
{"text": "( i )The IGF-1 concentration is age dependent .Hence age - adjusted reference values have to be provided by each manufacturer .However most available assays provide insufficient data for reliable interpretation of the IGF-1 results [ 56 ] .", "label": "", "metadata": {}, "score": "80.390495"}
{"text": "For patients on medical treatment for Cushing 's disease the following washout periods must be completed before screening assessments are performed .Inhibitors of steroidogenesis ( ketoconazole , metyrapone ) : 1 week .", "label": "", "metadata": {}, "score": "80.40871"}
{"text": "Options for Medical Therapy .Medical therapy aims to achieve complete remission .Thus criteria already discussed will guide therapeutic decisions .Any deviation will be discussed when appropriate .", "label": "", "metadata": {}, "score": "80.63725"}
{"text": "Thus , with reduced liver function a dose reduction is recommended .Gastrointestinal side - effects of bromocriptine ( nausea , vomiting , abdominal discomfort , constipation , or diarrhoea ) can be reduced by a very slow dose increase .", "label": "", "metadata": {}, "score": "80.647064"}
{"text": "A study of translocation of GLUT-4 to plasma membrane showed that tissue presented low levels of membrane - associated GLUT-4 .When in vitro stimulation was undertaken , tissue was capable to be responsive to insulin .", "label": "", "metadata": {}, "score": "80.85727"}
{"text": "Quality of Life The IGF-1 concentration has been shown to be a poor indicator of complete clinical remission .Thus , to assess the clinical efficacy of Pegvisomant therapy Quality of Life ( QoL ) Questionnaires specifically developed for acromegalic patients have been used to monitor clinical efficacy of the medication .", "label": "", "metadata": {}, "score": "81.128334"}
{"text": "Progressive disease will be defined as increased tumor size according to RECIST definitions .Study Type ICMJE .Interventional .Study Phase .Phase 2 .", "label": "", "metadata": {}, "score": "81.25798"}
{"text": "Alternate day injections of Pegvisomant failed to maintain IGF-1 within the age - adjusted range [ 170 ] .Peak serum Pegvisomant concentrations are attained between 33 - 77 hours after administration .", "label": "", "metadata": {}, "score": "81.2792"}
{"text": "About Starting Therapy .Before starting injections of Sandostatin \u00ae LAR Depot every 4 weeks , your doctor will start you on daily self - administered doses of immediate - release Sandostatin \u00ae ( octreotide acetate ) Injection .", "label": "", "metadata": {}, "score": "81.301994"}
{"text": "BACKGROUND : EMR is a viable alternative to surgery for removal of large mucosal neoplastic lesions of the entire GI tract .Few studies have , however , been published on the safety , efficacy , and technical aspects of EMR in the duodenum .", "label": "", "metadata": {}, "score": "81.48752"}
{"text": "Female sterilization ( have had surgical bilateral oophorectomy with or without hysterectomy ) or tubal ligation at least six weeks before taking study treatment .In case of oophorectomy alone , only when the reproductive status of the woman has been confirmed by follow up hormone level assessment .", "label": "", "metadata": {}, "score": "81.62044"}
{"text": "Well differentiated neuroendocrine tumors without disease progression .Patients with intolerance to somatostatin analogues .Gender .Both .Ages .18 Years to 80 Years .", "label": "", "metadata": {}, "score": "81.789055"}
{"text": "These assays are very sensitive with a lower limit of detection of 0.002 \u03bc g / L to 0.2 \u03bc g / L. Preanalytic handling is straight forward as GH , in a serum sample , remains stable for at least 24 hours [ 49 ] .", "label": "", "metadata": {}, "score": "81.79344"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : The syndrome of dyskinesia associated with hyperglycemia and basal ganglia hyperintensity on T1 - weighted MR images is rare and most often affects elderly patients with type 2 diabetes .", "label": "", "metadata": {}, "score": "81.903465"}
{"text": "OBJECTIVES : Correlate the GH secretion profile in healthy men older than 50 years with anthropometric parameters and exercise capacity .PATIENTS AND METHODS : Twenty - nine healthy male were selected , with a mean age of 57.9+/-4.2 years ( range 50 - 66 ) .", "label": "", "metadata": {}, "score": "82.02182"}
{"text": "More precise information on growth could help predict short - term outcomes and make decisions about when referral or intervention , if needed , should be initiated .", "label": "", "metadata": {}, "score": "82.20265"}
{"text": "Cholestatic liver dysfunction , with a histological diagnosis of drug - related liver toxicity , developed in a patient with Gilbert syndrome and resolved after treatment was stopped [ 194 ] .", "label": "", "metadata": {}, "score": "82.27228"}
{"text": "Aniszewski JP , Young WF , Thompson GB , Grant CS , van Heerden JA : Cushing syndrome due to ectopic adrenocorticotropic hormone secretion .World J Surg 2001 , 25:934 - 940 .", "label": "", "metadata": {}, "score": "82.27602"}
{"text": "The second generation DAs have to be taken daily ( Quinagolide ) or once to twice weekly ( Cabergoline ) .Increasing the dose to more than the recommended maximal dose does not increase efficacy , but results in worse side effects .", "label": "", "metadata": {}, "score": "82.55601"}
{"text": "Less common disorders with similar features may imitate preeclampsia though require different management strategies and with different prognostic implications for mother and baby .We present a case of a pregnant woman who developed severe hypertension and proteinuria in pregnancy .", "label": "", "metadata": {}, "score": "82.78243"}
{"text": "As the results of different assays are not comparable , each assay system needs its own reference value .This is important , since assay systems may change over time causing problems for the interpretation of results during long - term follow - up .", "label": "", "metadata": {}, "score": "82.79028"}
{"text": "He also drafted and edited the manuscript and obtained the patient 's consent and perspective .AZ searched for previous relevant cases in the literature and reviewed and edited the manuscript .", "label": "", "metadata": {}, "score": "82.895676"}
{"text": "Furthermore GH - receptor blockade induces a feedback increase of the endogenous GH concentration .Therefore the determination of GH can no longer be used as a parameter for therapeutic efficacy .", "label": "", "metadata": {}, "score": "83.16545"}
{"text": "For female subjects on the study the vasectomized male partner should be the sole partner for that subject .Combination of any two of the following ( a+b or a+c , or b+c ) : .", "label": "", "metadata": {}, "score": "83.29746"}
{"text": "19 - 25 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. L. Derr , S. J. Cameron , and S. H. Golden , \" Pre - analytic considerations for the proper assessment of hormones of the hypothalamic - pituitary axis in epidemiological research , \" European Journal of Epidemiology , vol .", "label": "", "metadata": {}, "score": "83.31957"}
{"text": "These symptoms are mostly due to an inhibition of the exocrine pancreas secretion .In rare cases problems persist with steatorrhea and malabsorption .The addition of pancreatic enzymes resolves these problems .", "label": "", "metadata": {}, "score": "83.353455"}
{"text": "Currently , the prognosis for patients with bronchial carcinoid EAS is good [ 1 - 4 ] , even when it persists or manifests as multiple lesions [ 5].", "label": "", "metadata": {}, "score": "83.52173"}
{"text": "Consistent with normal insulin receptor and post receptor signaling , our results were compatible with decreased insulin binding to IR probably due to neutralization by anti - insulin antibodies .", "label": "", "metadata": {}, "score": "83.57687"}
{"text": "However , if GH is normalised by SRL therapy , the drug induced suppression of insulin secretion , directly and via suppression of GLP-1 [ 92 ] , increases lipolysis .", "label": "", "metadata": {}, "score": "83.67182"}
{"text": "Technical Considerations .To establish the effect of surgical therapy several considerations have to be taken in account : .Timing of the Postoperative Evaluation .", "label": "", "metadata": {}, "score": "83.75679"}
{"text": "Possibly less Pegvisomant is needed when , due to the effect of SRL , less growth hormone is to compete with in the circulation .In addition , the reduction of insulin in the portal vein during SRL therapy will decrease the number of available GH - receptors and thus increase the efficacy of GH receptor blockade by Pegvisomant [ 178 ] .", "label": "", "metadata": {}, "score": "83.8575"}
{"text": "Conclusions The GH - receptor antagonist Pegvisomant normalises IGF-1 concentration in up to 97 % of the patients .The dose is titrated to normalize IGF-1 concentration , because GH can not be routinely measured and serve as an indicator for therapeutic efficacy , due to cross - reactivity of the routinely used GH assay with Pegvisomant .", "label": "", "metadata": {}, "score": "83.97162"}
{"text": "Thus peak - trough fluctuations at steady state during once daily dosing are small [ 171 ] .Pegvisomant circulates at concentrations 100 - 1000 times those of endogenous GH .", "label": "", "metadata": {}, "score": "84.09679"}
{"text": "A 25-year - old Arabic woman presented to our emergency department with rapid onset of headache , flaring acne and hirsutism , facial puffiness , weight gain and paroxysmal myopathy , and paranoiac thoughts of rape and sexual intimidation .", "label": "", "metadata": {}, "score": "84.11565"}
{"text": "In the early period , which spans the first few weeks after surgery , both monitoring of ... .BACKGROUND : Despite treatment , the mean final height ( FH ) of patients with classic congenital adrenal hyperplasia ( CAH ) is below the mean height of a normal population .", "label": "", "metadata": {}, "score": "84.12199"}
{"text": "Thus there is an increased risk of chronic gastritis and , with long - term therapy , a decline of the vitamin B12 concentration [ 97 , 98 ] .", "label": "", "metadata": {}, "score": "84.171974"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Dopamine receptor ( DR ) and somatostatin receptor subtype expression in pituitary adenomas may predict the response to postsurgical therapies .", "label": "", "metadata": {}, "score": "84.210205"}
{"text": "( iii )The variability of the IGF-1 determination can be substantial .Two samples , measured at baseline and after two weeks , showed an overall good correlation ( . %", "label": "", "metadata": {}, "score": "84.23913"}
{"text": "We evaluated the evidence of treatment and follow - up strategies for clinically nonfunctioning adenomas .PubMed was searched for articles on nonfunctioning adenomas in November 2007 , and references of ... .", "label": "", "metadata": {}, "score": "84.34881"}
{"text": "4 , pp .467 - 471 , 2008 .View at Publisher \u00b7 View at Google Scholar . A. F. Muller , J. A. Janssen , L. J. Hofland et al . , \" Blockade of the growth hormone ( GH ) receptor unmasks rapid GH - releasing peptide-6-mediated tissue - specific insulin resistance , \" Journal of Clinical Endocrinology and Metabolism , vol .", "label": "", "metadata": {}, "score": "84.39853"}
{"text": "Age was a significant risk factor , and hypertension and DM were significantly associated complications of SA .Obesity was also significantly related to SA , as a risk factor , a complication or both .", "label": "", "metadata": {}, "score": "84.61574"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Acromegaly is a systemic disease with various etiologies .It can occur as a sporadic or , more rarely , as a familial disease .", "label": "", "metadata": {}, "score": "84.690704"}
{"text": "Basal GH and IGF - I at diagnosis were 120 ng / mL and 114 % ULRV , respectively .Patient underwent non - curative trans - sphenoidal surgery .", "label": "", "metadata": {}, "score": "84.69458"}
{"text": "Basal GH and IGF - I at diagnosis were 120 ng / mL and 114 % ULRV , respectively .Patient underwent non - curative trans - sphenoidal surgery .", "label": "", "metadata": {}, "score": "84.69458"}
{"text": "Primary medical therapy is defined as any medical therapy instead of surgery .Possible indications for primary medical therapy are ( i ) patient 's preference , ( ii ) comorbidities that pose an anaesthetical or surgical risk , and ( iii ) possibly very old age [ 133 ] .", "label": "", "metadata": {}, "score": "84.75148"}
{"text": "A year and a half after surgery she regained weight .Her physical examination confirmed moon face and re - darkening of previous striae .Her UFC levels were high and remained unsuppressed by either low or high doses of dexametha- sone ( Table 1 ) .", "label": "", "metadata": {}, "score": "84.78319"}
{"text": "Mechanism of Tumour Shrinkage The mechanism of tumour shrinkage is still not fully understood .SRL are not cytotoxic .Tumour shrinkage is probably in part due to an inhibition of the GH synthesis and subsequent volume reduction of the intracellular organelles involved in hormone production and intracellular transport .", "label": "", "metadata": {}, "score": "84.856186"}
{"text": "In contrast , during Pegvisomant therapy , GH no longer stimulates lipolysis due to the blockade of its receptor , while insulin action is unabated .", "label": "", "metadata": {}, "score": "84.88889"}
{"text": "To show that CAH patients can achieve their target height ( TH ) , 39 adult subjects , whose therapy had started in infancy , were studied in a ... .", "label": "", "metadata": {}, "score": "84.97069"}
{"text": "Ectopic recurrences of craniopharyngiomas are very rare .We describe an adult patient with ectopic recurrence of craniopharyngioma , emphasizing unique features of the case presentation and its physiopathological aspects .", "label": "", "metadata": {}, "score": "84.9852"}
{"text": "Controlled mUFC ( mean urinary free cortisol)response of the two Pasireotide regimens by month 7 and 12 [ Time Frame : 12 months ] [ Designated as safety issue : Yes ] .", "label": "", "metadata": {}, "score": "85.0182"}
{"text": "Unfortunately shortly thereafter , the assay system used ( Nichols IGF-1 assay ) was no longer available .( ii )In patients with poorly controlled diabetes mellitus or malnutrition IGFBP-1 and IGFBP-2 concentrations increase , rendering the determination of IGF-1 difficult [ 40 ] .", "label": "", "metadata": {}, "score": "85.17174"}
{"text": "SRL induce the inhibition of cholecystokinin secretion and the synthesis of a more vicious and lithogenic bile , resulting in gallbladder sludge or gallstones in up to 30 % to 60 % of the patients , respectively [ 97 ] .", "label": "", "metadata": {}, "score": "85.264496"}
{"text": "Allocation : Non - Randomized Endpoint Classification : Safety / Efficacy Study Intervention Model : Single Group Assignment Masking : Open Label Primary Purpose : Treatment .", "label": "", "metadata": {}, "score": "85.26822"}
{"text": "Somatostatin Receptor Ligands ( SRL ) .Mechanism of Action GH secretion is physiologically regulated by the interaction of stimulating and inhibiting hypothalamic peptides , growth hormone releasing hormone , and somatostatin , respectively .", "label": "", "metadata": {}, "score": "85.427185"}
{"text": "However , as already discussed , receptor interactions modulated by subtype specific SRL may profoundly influence the mechanisms of action of SRL .In addition to the inhibition of GH secretion the native somatostatin , as well as the SRL , also reduce the secretion of insulin , glucagon , cholecystokinin and gastrin .", "label": "", "metadata": {}, "score": "85.481384"}
{"text": "Possible subcellular mechanisms of insulin resistance were investigated by performing analysis of insulin receptor and post receptor signaling in skeletal muscle biopsy .The expression of insulin receptor ( IR ) , insulin receptor substrate 1 ( IRS-1 ) and glucose transporter 4 ( GLUT-4 ) was evaluated in total extract from muscle tissue by Western blotting .", "label": "", "metadata": {}, "score": "85.542816"}
{"text": "Her physical examination revealed pronounced facial acne and hirsutism , oily skin , moon face , buffalo hump , and classical Cushing 's syndrome purplish skin striae in the abdominal , axillary , and flank regions .", "label": "", "metadata": {}, "score": "85.6517"}
{"text": "Laboratory exams revealed a well controlled diabetes mellitus [ glycemia 6.0 mmol / L ( 109 mg / dL ) , HbA1c 57 mmol / mol ( 7.4 % ) ] .", "label": "", "metadata": {}, "score": "85.75522"}
{"text": "Novartis Pharmaceuticals Corporation has updated the Privacy Policy for this website .Among other changes , the new policy explains how it applies when we communicate with you on different devices and through different services , and how your information helps us personalize your online experiences .", "label": "", "metadata": {}, "score": "86.03612"}
{"text": "The movement disorder did not improve with adequate glycemic control so haloperidol was started .Six weeks later she was seen on an outpatient basis .", "label": "", "metadata": {}, "score": "86.35464"}
{"text": "Out of 24 patients , 21 had SA ( 87.5 % ) , of which 20 ( 95.3 % ) had the predominant obstructive type .", "label": "", "metadata": {}, "score": "86.355675"}
{"text": "Depending on the individual situation ( obesity , metabolic syndrome , age )SRL can nevertheless induce diabetes mellitus .Patients with pre - existing diabetes mellitus may have an increased or reduced need of insulin treatment , and thus a tight control of blood sugar is mandatory in this group when SRL is initiated .", "label": "", "metadata": {}, "score": "86.37804"}
{"text": "Patients : 43 family members .Setting : University hospitals .Outcome : Genetic and endocrine screening of family members .One of the 2 index cases presented with gigantism and pituitary apoplexy and the other with young - onset acromegaly , and both had surgery and radiotherapy .", "label": "", "metadata": {}, "score": "86.51535"}
{"text": "were able to show a negative correlation between well - being and the IGF-1 concentration , that is , higher QoL with IGF-1 concentration approaching normal values [ 27 ] .", "label": "", "metadata": {}, "score": "86.72888"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : To determine the prevalence of sleep apnea ( SA ) and SA syndrome ( SAS ) in patients with acromegaly and correlate SA with clinical , laboratory , and cephalometric parameters .", "label": "", "metadata": {}, "score": "86.81157"}
{"text": "DAs bind preferentially with high affinity to dopamine 2 ( D2 ) receptors .Due to a high first - pass effect in the liver only 6 % of a given dose will appear in the peripheral circulation .", "label": "", "metadata": {}, "score": "86.93283"}
{"text": "Pegylation of the molecule prolongs the plasma half - life from 15 minutes to 72 hours [ 168 , 169 ] .Furthermore pegylation reduces immunogenicity of the molecule as well as interaction with GH - binding proteins [ 167 ] .", "label": "", "metadata": {}, "score": "87.101654"}
{"text": "Basal GH and IGF - I at diagnosis were 133 ng / mL and 181 % above the upper limit of reference values ( ULRV ) , respectively .", "label": "", "metadata": {}, "score": "87.17616"}
{"text": "Thorax CT revealed no tumoral lesion .Abdominal and pelvic MRI showed images suggestive of hepatic and iliac , femoral and lumbar secondary implants .[ ( 18)F ] FDG PET scan revealed intense uptake in uterus , especially cervix , suggesting this to be the primary tumor site .", "label": "", "metadata": {}, "score": "87.22483"}
{"text": "BACKGROUND :Information regarding the efficacy of growth hormone ( GH ) therapy in Asian Prader - Willi syndrome ( PWS ) patients is lacking .", "label": "", "metadata": {}, "score": "87.26862"}
{"text": "With Pegvisomant 40 mg / week QoL and symptoms scores improved .However , there was no correlation between the IGF-1 concentration and the improvement of QoL [ 190 ] .", "label": "", "metadata": {}, "score": "87.44774"}
{"text": "Because CPP is rare in boys , the majority of papers on this ... .Heyman Melvin B MB Department of Pediatrics , University of California San Francisco , San Francisco , CA 94143 - 0136 , USA .", "label": "", "metadata": {}, "score": "87.4769"}
{"text": "No .Contacts ICMJE .Contact information is only displayed when the study is recruiting subjects .NCT00990535 .Other Study ID Numbers ICMJE .NeuroendoUnit-6 .", "label": "", "metadata": {}, "score": "87.55129"}
{"text": "At the age of 8 years , a growth hormone ... .CONTEXT : Single - session stereotactic radiotherapy ( SR ) may be a potential adjuvant treatment in acromegaly .", "label": "", "metadata": {}, "score": "87.74767"}
{"text": "The Wilcoxon signed - rank test was used and values of 5 % were considered statistically significant .We found 16 ( 54 % ) patients with normal glucose tolerance , 7 ( 23 % ) with impaired glucose tolerance and 7 ( 23 % ) diabetics .", "label": "", "metadata": {}, "score": "88.07637"}
{"text": "To evaluate the incidence of gravid hysterectomy ( GH ) and to examine the indications as well as risk factors and complications associated with the procedure at an academic perinatal referral center .", "label": "", "metadata": {}, "score": "88.32553"}
{"text": "While most transsphenoidal pituitary surgery is accomplished without complication , monitoring is required postoperatively for a set of disorders that are specific to this surgery .", "label": "", "metadata": {}, "score": "88.5433"}
{"text": "The effect on adipose tissue and its consequences will have to be kept in mind .Liver function tests should be used to monitor therapy .", "label": "", "metadata": {}, "score": "88.65202"}
{"text": "Insulin sensitivity of basal lipolysis and endogenous glucose production were enhanced compared to baseline [ 187 ] .The fasting glucose- and insulin concentration , as well as the homeostasis model assessment index ( HOMA ) , an estimate of insulin resistance , declined during Pegvisomant compared to baseline .", "label": "", "metadata": {}, "score": "88.737656"}
{"text": "Case reports : Patient 1 : female , 36 years old at diagnosis .Basal GH and IGF - I at diagnosis were 133 ng / mL and 181 % above the upper limit of reference values ( ULRV ) , respectively .", "label": "", "metadata": {}, "score": "88.960495"}
{"text": "However , its safety during pregnancy is still uncertain .Its administration is usually stopped once pregnancy is confirmed [ 17].Information regarding its safety during pregnancy is sparse .", "label": "", "metadata": {}, "score": "89.013275"}
{"text": "METHODS : Two trained nurses visited all ... .The mode of treatment best for undescended testes is controversial , and local traditions often override knowledge gained from randomized controlled studies .", "label": "", "metadata": {}, "score": "89.0697"}
{"text": "Data provided are for informational purposes only .Although carefully collected , accuracy can not be guaranteed .The impact factor represents a rough estimation of the journal 's impact factor and does not reflect the actual current impact factor .", "label": "", "metadata": {}, "score": "89.30095"}
{"text": "Conclusions Monotherapy with a dopamine agonists should be considered as first - line treatment in patients with relatively low GH and IGF - I concentrations in view of their low cost and oral intake .", "label": "", "metadata": {}, "score": "89.41025"}
{"text": "Table 1 presents the patient 's relevant endocrine pro- file .High - dose ( 2 mg four times daily ) dexamethasone failed to suppress both serum cortisol and urinary free cortisol ( UFC ) levels .", "label": "", "metadata": {}, "score": "89.45943"}
{"text": "On this there is very little information .Our own investigation showed no positive effect of presurgical SRL treatment on the conservation of pituitary function [ 126 ] .", "label": "", "metadata": {}, "score": "89.49771"}
{"text": "They increase with the dose and can be prevented by a slow increase of the dose .Nausea and orthostatic dysregulation can be precluded by taking the dopamine agonist at bedtime .", "label": "", "metadata": {}, "score": "89.52605"}
{"text": "Normal IGF - I for age and sex was considered standard for control of disease activity .Correlations between basal and mean GH were studied as were correlations between both values and % IGF - I above the upper limit of reference values ( % ULRV ) .", "label": "", "metadata": {}, "score": "89.571365"}
{"text": "Other Side Effects Increase of Liver Enzymes Overall the drug is well tolerated and subjective complaints are few .An increase in liver enzymes has been observed and is reversible after ending treatment with Pegvisomant [ 192 ] .", "label": "", "metadata": {}, "score": "89.5874"}
{"text": "2Department of Pathology , G. Gennimatas Athens General Hospital , Athens , Greece.3Department of Medicine , E. Rambam Health Campus and Rappaport Faculty of Medicine , Technion , Haifa , Israel .", "label": "", "metadata": {}, "score": "89.75048"}
{"text": "After trees on 7564 ha of the Makawao Forest Reserve were damaged in 1977 , a study was begun to determine growth and refoliation response of ... .", "label": "", "metadata": {}, "score": "90.08269"}
{"text": "Of primary concern are fetal growth and growth hormone ( GH ) levels during fetal life .During the third trimester , increasing placental GH production leads to a significant rise in insuling - like growth factor 1 ( IGF-1 ) levels .", "label": "", "metadata": {}, "score": "90.94711"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : BACKGROUND :The use of growth hormone ( GH ) in deficient adults has already been demonstrated to result in several benefits regarding metabolic parameters , body composition and quality of life .", "label": "", "metadata": {}, "score": "91.75755"}
{"text": "You can print these questions , and bring them with you on your next doctor visit .There are 3 sets of questions , depending on where you are in your treatment .", "label": "", "metadata": {}, "score": "91.789185"}
{"text": "Yes .Plan to Share Data .Not Provided .IPD Description .Not Provided .Responsible Party .Annamaria Colao , Dept of Mol Clin Endocrinol Oncol , University Federico II of Naples .", "label": "", "metadata": {}, "score": "91.92171"}
{"text": "In rare cases an increase of liver function enzymes may occur .Thus control of these parameters is recommended every 6 months .Diffuse alopecia is rare and occurs less often with the subcutaneous than with the slow release preparation and is reversible after discontinuation .", "label": "", "metadata": {}, "score": "92.14865"}
{"text": "Genetic analysis of the ret proto - oncogene showed no mutation .Pituitary MRI was repeated 10 months after pheochromocytoma resection and revealed a slightly enlarged pituitary and partial empty sella .", "label": "", "metadata": {}, "score": "92.43024"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .L. Boero , M. Manavela , K. Danilowicz et al . , \" Comparison of two immunoassays in the determination of IGF - I levels and its correlation with oral glucose tolerance test ( OGTT ) and with clinical symptoms in acromegalic patients , \" Pituitary .", "label": "", "metadata": {}, "score": "92.68808"}
{"text": "Side - effects occur less often with the second generation DA .However DA may induce a psychosis and this can occur even after long - time exposure .", "label": "", "metadata": {}, "score": "92.853516"}
{"text": "In addition , you may want to ask your doctor : .When will my dosage be reviewed ?What are my current growth hormone ( GH ) and insulin - like growth factor-1 ( IGF-1 ) levels ?", "label": "", "metadata": {}, "score": "92.93811"}
{"text": "Jehle Sigrid S Department of Neurosurgery , Mount Sinai School of Medicine , New York , New York 10029 , - - 2008 .OBJECTIVES : Irritable bowel syndrome ( IBS ) is a functional disorder , which has recently been linked to immune activation .", "label": "", "metadata": {}, "score": "92.96817"}
{"text": "Recruiting Status : Enrollment is open .An Open - label study to assess the safety and efficacy of COR-003 ( 2S , 4R - Ketoconazole ) in the treatment of endogenous Cushing 's Syndrome .", "label": "", "metadata": {}, "score": "93.14372"}
{"text": "In a further meta - analysis Freda confirmed their earlier results [ 80 ] and added follow - up information .The response rate increased over time [ 46 ] .", "label": "", "metadata": {}, "score": "93.38928"}
{"text": "Lipohypertrophy In the German Acrostudy 12 out of 371 patients reported some degree of lipohypertrophy [ 193 ] .An impressive form of lipohypertrophy has been illustrated by Buyuktas et al . in one patient [ 196 ] .", "label": "", "metadata": {}, "score": "93.89169"}
{"text": "Conclusions Dopamine agonist drugs may be used after incomplete surgery in acromegalic patients .This is mainly recommended in patients with only modestly elevated GH / IGF-1 concentrations .", "label": "", "metadata": {}, "score": "93.96325"}
{"text": "Adipose tissue , the kidneys , and skeletal muscle seem to need less Pegvisomant to reduce GH actions compared to the liver where more Pegvisomant is required in order to reduce IGF-1 production [ 173 ] .", "label": "", "metadata": {}, "score": "94.90695"}
{"text": "Sexually active males must use a condom during intercourse while taking the drug and for 2 months after the last dose of study drug and should not father a child in this period .", "label": "", "metadata": {}, "score": "95.27489"}
{"text": "Pivonello Rosario R Department of Molecular and Clinical , Endocrinology , \" Federico II \" University , Via Sergio Pansini , 5 , 80131 Naples , Italy .", "label": "", "metadata": {}, "score": "95.39744"}
{"text": "Discrepancy between the GH Nadir during OGTT and the IGF-1 Concentration .The observed discrepancy between the GH nadir during an oral glucose load and the IGF-1 concentration is a major problem for the interpretation of biochemical indices of disease activity .", "label": "", "metadata": {}, "score": "95.41786"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : A woman with a previous history of hyperthyroidism and low thyroid radioiodine uptake was admitted .", "label": "", "metadata": {}, "score": "95.426735"}
{"text": "For general information , see Learn About Clinical Studies .Please refer to this study by its ClinicalTrials.gov identifier : NCT01374906 .ACTH - Secreting Pituitary Adenoma Adrenocortical Hyperfunction Cushing Syndrome Pituitary ACTH Hypersecretion Adenoma Adrenal Gland Diseases Brain Diseases Central Nervous System Diseases Endocrine Gland Neoplasms Endocrine System Diseases .", "label": "", "metadata": {}, "score": "95.543564"}
{"text": "The frequency in SA patients of impaired glucose tolerance , diabetes mellitus ( DM ) , and hypertension was 19 , 33.3 , and 71.4 % respectively .", "label": "", "metadata": {}, "score": "95.77211"}
{"text": "Reduced exercise capacity , lethargy , or sweating may be nonspecific .Follow - up and long - term observation of the quality of life ( QoL ) using an acromegaly adjusted questionnaire [ 25 , 26 ] can be helpful in assessing the activity of autonomous GH secretion .", "label": "", "metadata": {}, "score": "96.39345"}
{"text": "Common side effects : Most patients experience side effects at some time .Some common side effects you may experience include : .Other information : Patients with carcinoid tumors and VIPomas should adhere closely to their scheduled return visits for reinjection in order to minimize exacerbation of symptoms .", "label": "", "metadata": {}, "score": "96.59161"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : GH secretion , in acromegaly , is characterized by increased basal levels , as well as by increased frequency and amplitude of pulses .", "label": "", "metadata": {}, "score": "97.03824"}
{"text": "ACTH - Secreting Pituitary Adenoma Carcinoid Tumor Neuroendocrine Tumors Pituitary ACTH Hypersecretion Pituitary Neoplasms Prostatic Neoplasms Brain Neoplasms Central Nervous System Neoplasms Endocrine Gland Neoplasms Genital Neoplasms , Male Hypothalamic Neoplasms Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms , Germ Cell and Embryonal .", "label": "", "metadata": {}, "score": "97.182785"}
{"text": "METHODS : Forty - six PWS patients ( 27 males , 19 females ; age range , 1 year 4 months to 13 years 7 months ) ... .", "label": "", "metadata": {}, "score": "97.55592"}
{"text": "Apnea - hypopnea index ( AHI ) correlated significantly with age , waist circumference , body mass index , and hypopharynx area .The AHI was significantly higher in patients with hypertension and DM .", "label": "", "metadata": {}, "score": "97.78966"}
{"text": "11 Suppl , pp .21 - 27 , 2005 .View at Google Scholar .153 , no . 1 , pp .135 - 141 , 2005 .", "label": "", "metadata": {}, "score": "97.80671"}
{"text": "Recruiting Status : Enrollment is open .A phase III , multi - center , double - blind , randomized withdrawal study of LCI699 following a 24-week , single - arm , open - label dose titration and treatment period to evaluate the safety and efficacy of LCI699 for the treatment of patients with Cushing 's disease .", "label": "", "metadata": {}, "score": "99.15346"}
{"text": "Chest computed tomo- graphy revealed a 22 mm \u00d7 15 mm \u00d7 10 mm mass in the upper segment of the left lower pulmonary lobe .", "label": "", "metadata": {}, "score": "99.16582"}
{"text": "4465 - 4473 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .89 , no . 2 , pp .", "label": "", "metadata": {}, "score": "99.47243"}
{"text": "Patient 's perspective \" Soon after the disease remission I realized that I resumed my health .I felt powerful enough to challenge the illness and overcome it .", "label": "", "metadata": {}, "score": "99.55008"}
{"text": "The first success with treatment drove me to another two , thank God .All I need is a routine visit to the clinic , and doing some analysis .", "label": "", "metadata": {}, "score": "99.65034"}
{"text": "Research and Clinical Trials .Research .Body Composition and the Metabolic Syndrome in Cushing 's Disease .This is a longitudinal cohort study of patients with Cushing 's disease , which assesses the role of excess cortisol in the regulation of adipose tissue , appetite , and metabolic profile .", "label": "", "metadata": {}, "score": "99.762955"}
{"text": "To learn more about this study , you or your doctor may contact the study research staff using the Contacts provided below .For general information , see Learn About Clinical Studies .", "label": "", "metadata": {}, "score": "100.75389"}
{"text": "Barrier methods of contraception : Condom or Occlusive cap diaphragm or cervical / vault caps ) with spermicidal foam / gel / film / cream / vaginal suppository In case of use of oral contraception women should have been stable on the same pill for a minimum of 3 months before taking study treatment .", "label": "", "metadata": {}, "score": "100.79768"}
{"text": "The course of autosomal dominant polycystic kidney disease ( ADPKD ) is frequently complicated by infection of a cyst within a polycystic kidney , which is a diagnostic and therapeutic dilemma damaging the clinical course of patients .", "label": "", "metadata": {}, "score": "100.93097"}
{"text": "University of Perugia , Faculty of Medicine , Department of Internal Medicine Medical Therapy of Acromegaly .Interdisziplin\u00e4res Stoffwechsel - Centrum , Charit\u00e9 - Universit\u00e4tsmedizin Berlin , Campus Virchow - Klinikum , 13353 Berlin , Germany .", "label": "", "metadata": {}, "score": "100.96008"}
{"text": "GH reduces the insulin sensitivity .The reduction of the GH concentration by SRL thus improves insulin sensitivity and hence the drug - induced inhibition of insulin secretion can be without negative effects on glucose tolerance .", "label": "", "metadata": {}, "score": "101.06675"}
{"text": "5 , pp .701 - 705 , 2002 .View at Google Scholar \u00b7 View at Scopus .166 , no . 2 , pp .", "label": "", "metadata": {}, "score": "101.39526"}
{"text": "4 , pp .489 - 495 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . 94 , no .", "label": "", "metadata": {}, "score": "102.59572"}
{"text": "Generally GH concentrations are lower in older , obese , or male compared to younger , lean , or female subjects and patients [ 13 ] .", "label": "", "metadata": {}, "score": "102.75658"}
{"text": "6 , pp .1035 - 1042 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .140 , no .", "label": "", "metadata": {}, "score": "102.87547"}
{"text": "6 , pp .742 - 747 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . 7 , no . 3 , pp .", "label": "", "metadata": {}, "score": "103.09731"}
{"text": "Recruiting Status : Enrollment is open .Mount Sinai Faculty Practice 5 East 98th Street 7th floor New York , NY 10029 .Multidisciplinary Pituitary Conference .", "label": "", "metadata": {}, "score": "103.18584"}
{"text": "4 , pp .325 - 329 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . 86 , no . 1 , pp .", "label": "", "metadata": {}, "score": "104.29703"}
{"text": "With weekly intake , steady state is achieved after approximately 4 weeks .With a dose of 1.75 mg / week to 2.75 mg / week the GH concentration declined to below 2 \u03bc g / L in 46 % of the patients and the IGF-1 concentration was reduced to below 300 \u03bc g / L in 39 % [ 150 ] .", "label": "", "metadata": {}, "score": "105.12538"}
{"text": "Median GH level was 14 mug / l ( 1.4 - 198 ) and median % IGF - I ( percentage above the upper limit of normal range of IGF - I ) was 181 % ( -31.6 to 571.2 ) .", "label": "", "metadata": {}, "score": "105.50148"}
{"text": "103 - 110 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .90 , no .6 , pp .", "label": "", "metadata": {}, "score": "105.697235"}
{"text": "518 - 523 , 1997 .View at Publisher \u00b7 View at Google Scholar .116 , no . 2 , pp .287 - 292 , 1987 .", "label": "", "metadata": {}, "score": "105.73149"}
{"text": "775 - 779 , 1998 .View at Publisher \u00b7 View at Google Scholar .84 , no .6 , pp . 1986 - 1991 , 1999 .", "label": "", "metadata": {}, "score": "105.856346"}
{"text": "5 , pp .869 - 872 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .95 , no .", "label": "", "metadata": {}, "score": "105.915245"}
{"text": "Acknowledgements The authors express their gratitude to Prof Eddy Karnieli for his critical reading of the manuscript and for his remarks , as well as to his administrative assistant , Margalit Levi , who was helpful in editing the manuscript .", "label": "", "metadata": {}, "score": "106.26417"}
{"text": "In a large survey comprising 307 patients an increase in pituitary volume was reported in 18 ( 5.9 % ) of the patients [ 191 ] .", "label": "", "metadata": {}, "score": "106.54413"}
{"text": "Consent Written informed consent was obtained from the patient for publication of this case report and any accompany- ing images .A copy of the written consent is available for review by the Editor - in - Chief of this journal .", "label": "", "metadata": {}, "score": "106.74152"}
{"text": "94 , no . 2 , pp .523 - 527 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "107.25488"}
{"text": "Choosing to participate in a study is an important personal decision .Talk with your doctor and family members or friends about deciding to join a study .", "label": "", "metadata": {}, "score": "108.17581"}
{"text": "153 , no . 1 , pp .67 - 71 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "108.22638"}
{"text": "BACKGROUND : Noonan syndrome ( NS ) is an autosomal dominant inherited disease , characterized by a distinctive facial appearance , congenital heart defects , and short stature .", "label": "", "metadata": {}, "score": "108.88882"}
{"text": "476 - 482 , 2007 .View at Publisher \u00b7 View at Google Scholar .154 , no . 3 , pp .467 - 477 , 2006 .", "label": "", "metadata": {}, "score": "109.04285"}
{"text": "64 , no . 3 , pp .245 - 249 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "109.25333"}
{"text": "771 - 776 , 1990 .View at Google Scholar \u00b7 View at Scopus .93 , no .4 , pp .1254 - 1262 , 2008 .", "label": "", "metadata": {}, "score": "110.5491"}
{"text": "The changes in management strategy , the importance of a multidisciplinary approach to care , and the prognostic implications for the mother are discussed .\u00a9", "label": "", "metadata": {}, "score": "110.55538"}
{"text": "305 - 310 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .90 , no .12 , pp .", "label": "", "metadata": {}, "score": "111.552414"}
{"text": "287 - 292 , 2002 .View at Google Scholar \u00b7 View at Scopus . 13 , no . 1 , pp .18 - 28 , 2010 .", "label": "", "metadata": {}, "score": "112.09238"}
{"text": "RESULTS :During following - up of 13.0+/-3.2 months , neither remained tumor was found except one patients with ... .In boys , central precocious puberty ( CPP ) is the appearance of secondary sex characteristics driven by pituitary gonadotropin secretion before the age of 9 years .", "label": "", "metadata": {}, "score": "115.69014"}
{"text": "In my opinion having and growing babies , is a clear declaration that I won the combat !I wanted to see them leaving to the kindergar- ten with bags on their shoulder , exactly the same way other mothers say ' Bye bye ' to their children .", "label": "", "metadata": {}, "score": "116.65454"}
{"text": "Not Provided .Recruitment Information .Recruitment Status ICMJE .Completed .Enrollment ICMJE .Completion Date .December 2008 .Primary Completion Date .December 2007 ( final data collection date for primary outcome measure ) .", "label": "", "metadata": {}, "score": "118.857574"}
{"text": "3348 - 3356 , 2008 .View at Publisher \u00b7 View at Google Scholar .86 , no .4 , pp .1716 - 1723 , 2001 .", "label": "", "metadata": {}, "score": "118.96739"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .62 , no . 3 , pp .282 - 288 , 2005 .", "label": "", "metadata": {}, "score": "119.97611"}
{"text": "Competing interests The authors declare that they have no competing interests .Received : 27 April 2010 Accepted : 16 August 2011Published : 16 August 2011", "label": "", "metadata": {}, "score": "123.56153"}
{"text": "Academic Editor : A. L. Barkan .Copyright \u00a9 2012 U. Pl\u00f6ckinger .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "126.77321"}
{"text": "Learn more and view our schedule", "label": "", "metadata": {}, "score": "142.01436"}
